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ABSTRACT 
 This dissertation structurally examines the intermolecular self-association and 
quaternary structure of interleukin-2 tyrosine kinase (Itk) and draws conclusions about its 
relationship to the regulation and signaling of this immunologically important protein.  
Found primarily in haematopoietic cells, Itk is a member of the Tec family, the second 
largest family of non-receptor tyrosine kinases.  All Tec family members share an SH3, 
SH2, and catalytic kinase domain structure.  The activation of Itk occurs following T-cell 
receptor response to antigen stimulation.  The exact mechanism of regulation in Tec 
family kinases is unclear.  However, intermolecular self-association is emerging as a 
common characteristic among many members of the Tec family.   
 To explore the potentially functionally significant self-association in Itk, high-
resolution NMR solution structures were solved for the Itk SH3 domain, the Itk SH2 
domain, and the Itk SH3/SH2 complex.  The non-classical interaction between the Itk 
SH3 and SH2 domains mediates, in part, the self-association of full length Itk.  The 
structure of the SH3/SH2 complex provides insight on how isomerization of a proline 
imide bond acts as an intrinsic molecular switch that preorganizes the CD loop of the 
SH2 domain for a non-classical interaction with the SH3 domain.  Additionally, the 
oligomeric state of Itk self-association is characterized and the SH3/SH2 domain 
complex is used as a starting point to generate a structural model of the Itk SH3-SH2 
fragment self-association that accounts for the oligomerization seen in native gel analysis.  
The same SH3/SH2 interaction is mutually exclusive with a quaternary structural 
rearrangement that supports autophosphorylation.  Therefore, a structural model is 
described for Itk autophosphorylation that was generated using a previous point 
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mutational analysis of the Itk SH2 domain coupled with covalent bond restraints found in 
the linkers of the SH3-SH2-kinase fragment.  These studies bring us closer to 
understanding the structural mechanism behind Itk self-association and describe a model 
for one of many quaternary structural conformations in which Itk is likely to exist. 
 
 1 
CHAPTER 1.  INTRODUCTION 
Literature Review 
T-cells 
 T-cells have an important role in immune response.  After their creation in the 
bone marrow, immature T-cells travel to the thymus where non-self antigen recognizing 
T-cells are allowed to mature and circulate through the blood, secondary lymphoid 
tissues, and lymph.  Upon activation by an antigen, a signal is passed from the T-cell 
receptor to a biochemical-signaling cascade resulting in Ca++ mobilization and 
transcription factor activation leading to cytokine signaling and differentiation.  Cytokine 
release from T-cells recruit macrophages and help B-cells to release antibodies that bind 
the pathogen, fix complement, and lead to opsonization and ultimately phagocytosis of 
the pathogen 1.  The biochemical-signaling cascade that results in T-cell activation 
requires the Tec family member, Interleukin-2 tyrosine kinase (Itk) for proper immune 
response 2. 
 
Interleukin-2 tyrosine kinase 
 Interleukin-2 tyrosine kinase was first discovered by a PCR screen using primers 
based on conserved tyrosine kinase regions and a cDNA library made from mouse 
thymus 3.  Well characterized in T-cells, Itk is important in T-cell development and 
proliferation 4.  Itk-/- knockout mice have a reduced number of T-cells 5. These Itk 
deficient T-cells show impaired T-helper cell differentiation and response 6; 7.  In double 
knockout Itk-/- Rlk-/- mice where Rlk is a kinase in the same family as Itk, proliferation 
and cytokine production are severely affected.  More recently, Itk has been implicated in 
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cell adhesion, actin cytoskeletal rearrangement, 8; 9 and in the HIV replication pathway 10.  
Overall, Itk is an important regulator of T-cells and T-cell receptor signaling in response 
to antigen stimulation. 11; 12.   
 Itk is a member of the Tec family of non-receptor tyrosine kinases along with Btk, 
Rlk, Bmx, and Tec.  Tec kinases are found in a variety of haematopoietic cells: T-cells, 
B-cells, mast cells, natural killer cells, and thymocytes 2.  The importance of the Tec 
family in human health became apparent after discovering the link between the immune 
disease X-linked agammaglobulinema (XLA) and the Tec kinase Btk 13; 14; 15.  This same 
disease is referred to as X-linked immunodeficiency (XID) in mice and has been used as 
a model system for the human disease.  XLA results in marked decreases in antibody 
production and impairs B cell development causing recurring bacterial infections that are 
sometimes lethal for individuals that inherit this disease 16.  Mutations that lead to XLA 
have been identified throughout the entire Btk protein.  All Tec kinases except Rlk have 
the following domain structure: Pleckstrin homology (PH), Tec homology (TH), Src 
Homology 3 (SH3) domain, Src Homology 2 (SH2) domain and the catalytic kinase 
domain (Figure 1).   
 
Tec Kinase Domain Architecture 
 
Figure 1: Tec kinase family domain structure 
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Rlk contains a poly-cysteine N-terminal tail region in place of the PH and TH domains.  
Two of the domains, SH2 and SH3, have been identified as important targeting domains 
for proper cell signaling 17.  In the Tec kinase Itk, the SH2 and SH3 domains form a non-
classical intermolecular interaction that is thought to be part of a functionally relevant 
self-association 18; 19; 20. 
 The SH2 domain has been identified in over a hundred proteins in the human 
genome alone21; 22.  The Src homology 2 (SH2) domain was discovered as a conserved 
sequence among cytoplasmic protein-tyrosine kinases consisting of approximately 100 
residues N-terminal to the catalytic domain 23; 24; 25.  Early coimmunoprecipitation 
experiments on the SH2 domain containing transforming protein P47gag-crk indicated a 
propensity of SH2 domains for binding to phosphotyrosine containing proteins 26; 27.  
Over time, the phosphotyrosine containing peptide became known as the canonical 
binding ligand for SH2 domains as more and more phosphotyrosine-containing SH2 
domain targets were identified.  Structural analysis from NMR and X-ray crystallography 
revealed the SH2 structure to consist of an antiparallel β sheet sandwiched between two 
α helices (Figure 2) 28; 29; 30.  Insight into the binding of canonical phosphotyrosine 
containing peptides was revealed from peptide bound crystal structures of SH2 domains 
31; 32; 33.  Two general classes of binding were identified for the SH2 domain.  Both 
classes have a deep pocket containing a buried arginine residue that binds the 
phosphotyrosine in the ligand.  The Itk SH2 domain falls into the first class of 
phosphopeptide binding where a second deep binding pocket is available for the binding 
of an Ile/Pro residue at position three residues C-terminal to the phosphotyrosine (pY+3).  
In the second class, a binding groove is observed that accommodates residues one to six 
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residues C-terminal to the phosphotyrosine (pY+1 through pY+6) 34.  Recently, a 
growing number of non-canonical binding partners have been discovered increasing the 
binding diversity of this modular domain 34; 35; 36; 37; 38; 39; 40; 41; 42; 43; 44.  
 
SH2 Domain Structure 
 
 
 
Figure 2: Structure of Itk SH2 domain (pdbcode 2LUN).  Secondary structure is colored 
green, yellow, and red, for loop, strand, and helix.  Residues in the conserved binding 
pockets are represented as sticks and circled.  
 
Of these non-canonical SH2 domain interactions, there are three structures in the PDB 
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between an SH2 domain and another protein in a protein-protein complex not including 
the SH3/SH2 complex that is discussed in Chapter 4 45; 46; 47.  There are several reviews 
that provide a comprehensive overview on the relevant research for SH2 domains 25; 43. 
At about the same time as the SH2 domain discovery, another homology region 
that was often found adjacent to SH2 domains was identified 48.  This domain, consisting 
of approximately 60 residues in length and found in a wide variety of proteins, 49 also 
showed homology with a region in the non-receptor protein tyrosine kinases.  This 
homology region was named Src Homology 3 (SH3). 27; 50.   It too has been identified in 
over 100 proteins in the human genome 21.  A screen of the SH3 domain from the non-
receptor tyrosine kinase Abl against a bacteriophage cDNA expression library resulted in 
the identification of proteins that bind SH3 domains 51 from which the canonical 
recognition motif of proline containing peptides was determined 52.  Structural analysis 
from NMR and X-ray crystallography revealed the SH3 domain structure of two β-sheets 
that wrap around each other to form a β-barrel (Figure 3) 49.  Insight into the binding of 
canonical proline containing peptides was revealed from peptide bound crystal structures 
of SH3 domains 45; 46; 53; 54.  The binding surface consists of a flat hydrophobic patch with 
three binding sites that interact with the ligand.  In the first two binding site, prolines in 
the canonical ligand interact with conserved tyrosines or phenylalanines.  In the third 
binding site, a charged residue in the canonical ligand forms a salt bridge with a 
conserved glutamate of the SH3 domain.  The N or C-terminal location of the positively 
charged residue that forms the salt bridge with the conserved glutamate provides two 
general classes of binding for the SH3 domain.  Itk falls into the first class in which the 
positively charged residue of the ligand is N-terminal resulting in a consensus motif of 
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(R/K)XXPXXP.  Here R, K, and P correspond to the single letter code for their respective 
amino acids and X represents any amino acid at that position.  In the second class, the 
positively charged residue of the ligand is C-terminal resulting in a consensus motif of 
PXXPX(R/K) 49; 55.   
 
SH3 Domain Structure 
 
 
Figure 3: Structure of Itk SH3 domain (pdbcode 2RNA).  Secondary structure is colored 
green, yellow, and red, for loop, strand, and helix.  Residues in the conserved 
hydrophobic patch are represented as sticks and circled in the structure on the right. 
 
A significant number of non-canonical binding partners have more recently been 
discovered for SH3 domains 36; 42; 43; 53; 56; 57; 58; 59; 60; 61; 62; 63; 64; 65; 66.  Of these non-
canonical SH3 domain interactions, there are five structures in the PDB between an SH3 
domain and another protein in a protein-protein complex not including the SH3/SH2 
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interaction discussed in Chapter 4 45; 46; 47; 67; 68. There are several reviews that provide a 
comprehensive overview on the relevant research for SH3 domains 49; 69 
 
Itk structural characterization 
 The Itk SH3 and SH2 domains proved to be readily expressed and amenable to 
study by NMR.  A construct containing both the proline rich region and the SH3 domain  
of Itk sequence was created and the NMR solution structure of this construct, named Itk 
PrSH3, indicated an intramolecular interaction between the SH3 domain and the adjacent 
proline rich region 55.  Similar intramolecular interactions with modest binding affinity 
have been shown to be important in Src kinase regulation and therefore were originally 
hypothesized to be important in Tec kinase family regulation. 
 This structural work was followed by NMR analysis of the SH3-SH2 dual domain 
fragment.  This fragment had a greater than expected line broadening for a protein of its 
size.  It was discovered that a novel interaction between the Itk SH2 and SH3 domains 
existed and the line broadening was a result of the dual domain fragment self-associating 
in a specific non-canonical manner 18.  At this point, the structure of the Itk SH2 and 
therefore this complex were unknown.  When the solution NMR structure of the SH2 
domain was solved, it contained an interesting molecular feature.  An intrinsic molecular 
switch was discovered70; a proline residue in the CD loop undergoes a slow exchange 
cis/trans isomerization of Asn286-Pro287 peptide bond resulting in two stable 
conformations in solution and the appearance of double resonances for approximately 
one third of the HSQC spectrum 70.  In one conformation, the trans conformer, it binds 
the canonical phosphotyrosine containing ligands.  In the other conformation, the cis 
 8 
conformer, it binds the SH3 domain.  It was later determined that the two conformational 
states only alter the binding affinity for these two ligands 71.  The complex between the 
trans conformer of the Itk SH2 and its classical ligand was solved in 2006 72.  The 
complex between the cis conformer of Itk SH2 and the SH3 domain will be discussed in 
Chapter 4. 
 
Itk activation and signaling 
 All members of the Tec family kinases require three main steps for activation: 
localization of the kinase to the membrane, association of the kinase with adaptor protein, 
and transphosphorylation of kinase by the Src family kinases 2.  
 
 
Figure 4:  Itk activation and signaling downstream of antigen stimulation of the TCR. 
Adapted from Berg et al. 2005 2.  
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T-cell activation by T-cell receptor stimulation of an antigen-containing major 
histocompatability complex (MHC) on an antigen-presenting cell results in the activation 
of phosphoinositide 3-kinase (PI3K) and ZAP-70.  PI3K increases phosphotidyl inositol 
(3,4,5) triphosphate (PIP3) concentrations near the TCR signaling complex while ZAP-70 
phosphorylates LAT allowing it to bind SLP-76 and form an adaptor protein complex.  
The PH domain of the Tec family member, Itk, binds PIP3 and the SH3 and SH2 domains 
of Itk bind the SLP-76/LAT complex resulting in localization of Itk to the membrane and 
association of Itk with an adaptor protein complex.  The Src family kinase Lck 
phosphorylates Itk on Tyr511 completing the three main steps for Tec kinase activation.  
Itk activation amplifies signaling cascades important in actin reorganization, 
transcription, adhesion, and Ca2+ mobilization resulting in IL-2 cytokine release.  Itk 
initiates these signaling events through the association and stabilization of Vav and the 
phosphorylation of PLCγ on Tyr783 (Figure 4) 2.  Despite our current knowledge of Itk 
activation and many of its down-stream signaling effects, there is a void in our 
understanding of the molecular mechanism of Tec family regulation. 
 
Regulation in Src family kinases 
The Src family is the largest family of non-receptor tyrosine kinases and is homologous 
to the Tec family.  SH2 and SH3 domains are important for inhibition of Src non-receptor 
tyrosine kinases 54.  As shown in Figure 5, the SH2 and SH3 domain do not block the 
activation site near the activation loop but rather turn inward and bind with modest 
 10 
affinity to intramolecular ligands locking the kinase in an inhibited conformational state.  
Located on the side opposite to the binding site for the kinase domain, the SH3 domain 
binds the linker sequence between the SH2 and kinase domains while the SH2 domain 
binds the phosphotyrosine 527 in the C-terminal tail 73 in a canonical interaction. 
 
 
Figure 5: Crystal structure of Src (pdbcode 2SRC).  Cartoon representation of the SH3, 
SH2, and Kinase domains.  An ATP molecule represented as spheres is located in the 
active site of the kinase domain.  This figure was generated in PyMOL74. 
 
This conformational state deforms the protein causing a displacement in the C-
helix removing a catalytically important glutamate residue from the active site.  This 
deformation also creates a small helix in the activation loop sequestering tyrosine 416 
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from phosphorylation.  The phosphorylation of this residue is required for full activation 
of the Src kinase.  The intramolecular peptide ligands are less than ideal binding partners 
for the SH2 and SH3 domains.  The SH3 intramolecular ligand forms a poly proline type 
II helical conformation, however, does not contain the canonical PXXP motif resulting in 
only modest binding affinity.  The SH2 intramolecular ligand contains a glycine at the 
pY+3 binding position that also reduces binding affinity.  The kinase domain becomes 
activated when a high-affinity binding partner for either the SH3 or the SH2 domain out 
competes one or both of the intramolecular ligands and unlocks the kinase-inhibited 
conformation.  If either of these intramolecular interactions are disrupted it leads to 
kinase activation.  In fact, the mutation Y527F is a cancer causing mutation that results 
from unregulated Src kinase activation 75. 
 
Itk Regulation 
 
Figure 6: Comparison of Tec vs. Src domain structure.  Tec family kinases lack the C-
terminal tail important in Src family kinase regulation. 
 
 Based on the gene sequence and the sequence of other Tec family members 
(Figure 6), it was apparent that Itk and all members of the Tec family kinases are not 
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regulated in the same way that Src family kinases are regulated.  Tec family kinases lack 
the C-terminal tail containing tyrosine (Src Tyr-527) that would bind the SH2 domain, 
which is important in Src kinases to stabilize the inhibited conformation (Figure 5).  In an 
effort to determine a regulatory mechanism for Itk, early structural work focused on the 
same two regulatory domains adjacent to the catalytic kinase domain.  Although the 
mechanism of regulation in Itk is different, it was thought that the SH2 and SH3 domains 
likely have an important functional role that effects kinase activity [[Andreotti, 1997 
#527; Severin, 2009 #683]]. 
 
Functionally relevant self-association 
 An investigation of the literature on Tec family kinases reveals that many of the 
members contain a mechanism for intermolecular self-association 71; 76; 77; 78; 79; 80.  It is 
believed that this intermolecular self-association may have an important functional 
relevance.  Btk, a member of the Tec family, associates intermolecularly through two 
proline rich regions adjacent to the SH3 domain 79.  The structure of the PH domain 
crystallizes as a dimer with two molecules present in the asymmetric unit 76; 81.   
Similarly, the PrSH3 fragment of the Tec family member Rlk associates intermolecularly 
through its SH3 domain and adjacent proline rich region 80.  Beside the intermolecular 
association between the SH3 and SH2 domain mentioned above there is another 
intermolecular interaction found in the PH domains82, full length Itk co-
immunoprecipitates with itself 82; 83, and forms intermolecular clusters at the T cell 
receptor upon T cell activation 84. 
 To better understand the role of Itk self association, a full length Itk mutant 
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construct was created that disrupts the binding affinity between the SH2 and SH3 
domains but maintains canonical binding properties (unpublished data of L. Min and W. 
Wu).  This was achieved by replacing the Itk SH3 domain with the Btk SH3 domain to 
form a chimeric ItkBtkSH3 construct.  The Btk SH3 domain shows no affinity for the Itk 
SH2 domain but maintains an affinity for the canonical proline-rich peptide derived from 
SLP-76 (Q184QPPVPPQRPMA195) indistinguishable from that of Itk SH3 domain.  In 
vitro kinase assays 85 show that the enzyme activity of the ItkBtkSH3 construct increases 
linearly with enzyme concentration while the enzyme activity of the wild type Itk 
construct decreases with increased kinase concentration.  This observation suggests a 
functional role of kinase inhibition for the Itk SH3/SH2 interaction.  In vivo experiments 
also support this speculation.  Wild type Itk and ItkBtkSH3 were retrovirally transduced into 
Itk-/- primary CD4 T cells and p42/44 ERK Map kinase phosphorylation was monitored 
to ascertain Itk kinase activity 86.  There was higher ERK activation following T-cell 
receptor stimulation for the ItkBtkSH3 mutant than wild type Itk.  The evidence described 
above strongly suggests a functionally relevant kinase-inhibiting role for the SH3/SH2 
interaction.  In this dissertation, I solve the structure of the SH3/SH2 binary complex and 
extend our understanding of Itk intermolecular self-association. 
 
Dissertation organization 
 This dissertation consists of seven chapters: a general introduction, followed by 
five chapters, and a general conclusion.  The chapter review presented in Chapter 1 
contains the necessary background information and current status of research on Itk 
structure, signaling, and regulation.  Chapter 2, is published in the Journal of 
 14 
Biomolecular NMR, describes the solution structure of the unbound Itk SH3 domain and 
describes how small structural changes within the SH3 binding pocket may accommodate 
classical ligand binding.  Chapter 3 describes the structural refinement of the Itk SH2 
domain using RDC restraints.  Chapter 4 is published in the Journal of Molecular 
Biology.  It describes the binary complex formed by the Itk SH3 and SH2 domains and 
how the cis SH2 conformer is pre-organized to form a hydrophobic interface with the 
SH3 domain.  Chapter 5 describes the oligomeric state of Itk using native gel analysis and 
structural modeling in Xplor-NIH.  Chapter 6 describes a structural model of Itk 
autophosphorylation that depends on the docking of the Itk SH2 domain to the kinase 
domain with a surface that is mutually exclusive with the SH2/SH3 binding surface.  The 
conclusions chapter contains a summary of the research presented in this dissertation, and 
implications to Itk regulation and signaling. 
 As the primary author, I carried out most of the experiments in Chapters 2 and 4.  
The refined structure in Chapter 3 makes use of some structural restraints obtained 
previously by Robert Mallis.  I performed all experiments described in Chapter 5.  In 
Chapter 6, I benefited greatly from lengthy discussions with Raji Joseph about the 
autophosphorylation model presented there. 
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Abstract 
 The SH3 domain of the immunological tyrosine kinase, Itk, exhibits unusual 
ligand recognition.  In addition to binding canonical proline rich sequences, this SH3 
domain interacts in an intermolecular fashion with the SH2 domain of Itk.  The SH3/SH2 
complex mediates self-association of full length Itk and is therefore of interest in 
understanding Itk regulation during T cell signaling.  As a first step toward solving the 
structure of the Itk SH3/SH2 complex, the high-resolution solution structure of murine 
Itk SH3 domain was solved using NOE, RDC, J-coupling, hydrogen bond, and backbone 
atom chemical shift derived torsion angle restraints.    The structure of the free Itk SH3 
domain allows for a direct comparison with a previously solved ligand bound Itk SH3 
domain.  Small structural changes within the SH3 binding pocket to accommodate ligand 
binding are described.   
 
Biological context 
 
 Interleukin-2 tyrosine kinase (Itk) is a non-receptor tyrosine kinase of the Tec 
family that is activated upon antigen binding to the T cell receptor 1; 2.  Itk is comprised 
of four regulatory domains: PH (Pleckstrin homology), TH (Tec homology), SH3, SH2 
and the catalytic kinase domain.  SH3 domains share a common fold consisting of five 
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anti-parallel β strands that form a β barrel and bind canonical proline rich ligands as well 
as a variety of non-canonical ligands 3.  
In contrast to Src family kinases 4, Tec family kinases lack the C-terminal 
regulatory phosphorylation site and consequently must be regulated by a distinct 
mechanism.  We previously reported that the Itk SH3 domain binds the Itk SH2 domain 
in a novel non-canonical fashion 5; 6.  The classical PXXP motif that is often the target of 
SH3 domains is not present in the Itk SH2 domain.  Correspondingly, the classical 
phosphotyrosine motif recognized by SH2 domains is not present in the Itk SH3 domain.  
We have found that disruption of the non-canonical SH3/SH2 intermolecular interaction 
in the context of full length Itk leads to an increase in Itk activity (Min, Andreotti et al., 
submitted).   Thus, the interaction between these domains plays a regulatory role in Itk 
mediated signaling and currently efforts are aimed at determining the structure of the 
SH3/SH2 complex.  Chemical shift perturbation mapping of the interface residues of the 
SH3/SH2 complex has been done and indicates that binding contacts are concentrated in 
the canonical binding pocket of the SH3 domain and the CD and BG loops of the SH2 
domain 5. 
A previously solved structure (pdb: 1awj) contained the Itk SH3 domain plus the 
adjacent N-terminal proline-rich region of Itk 7, henceforth called PrSH3.  The proline 
stretch binds to the Itk SH3 domain in an intramolecular fashion 7; 8 and the 
corresponding structure is therefore not a suitable model for determining the structure of 
the SH3/SH2 complex.  Conjoined rigid body/torsion angle-simulated annealing that is 
used to solve structures of protein complexes relies on the basic assumption that the 
unbound and bound structures are similar and do not undergo large conformational 
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changes upon binding 9.  In order to utilize the PrSH3 structure, the N-terminal proline-
rich region containing 16 residues would need to be removed leaving the remaining 
residues in a ligand bound conformation.  With the differences in the nature of the two 
ligands, proline-rich peptide chain versus protein surface (SH2 domain), the basic 
assumption that the bound and unbound structures are similar may not be met.  Thus, the 
high-resolution solution structure of the unbound Itk SH3 domain is presented here as the 
first step toward solving the structure of the Itk SH3/SH2 complex.   
 
Methods and Results 
 
NMR sample preparation 
 
 Protein expression and purification were performed as described previously 5.  
The NMR sample consisted of 1.5 mM 13C, 15N labeled Itk SH3 domain, 50 mM NaPO4, 
75 mM NaCl, 2 mM dithiothreitol (DTT), 5% D2O and 0.02% (w/v) NaN3 at pH 7.4.  
 
NMR Spectroscopy 
 
 All NMR spectra were collected at 298 K on a Bruker AVII 700 spectrometer 
equipped with a 5mm HCN z-gradient cryoprobe operating at 700.133 MHz 1H 
frequency.  Chemical shift assignments were elucidated from double and triple resonance 
experiments: CBCA(CO)NH, HNCACB, HBHA(CO)NH, HBHANH, HNCO, 
(HB)CB(CGCDCE)HE, (HB)CB(CGCD)HD, and HCCH-TOCSY, along with a 3D 15N-
edited TOCSY and 2D homonuclear TOCSY.  NOE correlations were obtained from a 
2D homonuclear NOESY, 3D 13C-edited aliphatic NOESY, 3D 13C-edited aromatic 
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NOESY, and 3D 15N-edited NOESY spectra.  All NOESY experiments were acquired 
with a mixing time of 100 ms.  
 IPAP 1H-15N correlation experiments were performed to measure residual dipolar 
coupling constants.  DNH values were determined from the difference between splittings 
recorded in anisotropic (J+D) and isotropic (J) media. Weak anisotropic alignment was 
achieved through the addition of 22.5 mg mL-1 of Pf1 phage 10; 11.  
 J-coupling data were collected from a quantitative J correlation HNHA 
experiment 12.  The J-coupling constants were included as restraints in the Xplor-NIH 
structure calculation with the following Karplus coefficients and phase: A=6.98, B=-1.38, 
C=1.72, phase=-60.0. 
Backbone torsion angle (φ, ψ and ω) data were obtained from 1HN, 15N, 1Hα, 
13CO and 13Cβ chemical shifts using PREDITOR 13.   Only those angles with a 
confidence greater than or equal to 0.5 were included.  J coupling phi restraints gathered 
from J-coupling data were given precedence and the corresponding phi angles obtained 
from PREDITOR were excluded. 
 Backbone hydrogen bonds were identified from a long range coupling HNCO 
hydrogen bond experiment 14.  Two structural restraints were added in Xplor-NIH 15 for 
each hydrogen bond: one restraint between the donor hydrogen and acceptor oxygen (1.5-
2.3 Å) and one restraint between the donor nitrogen and acceptor oxygen (2.5-3.3 Å).  All 
spectra were processed using TOPSPIN 1.3 and analyzed with CARA (Computer Aided 
Resonance Assignment) for chemical shift and NOE assignments 16.   
 
Resonance assignments for Itk SH3 domain 
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CARA provides very effective modular tools to facilitate the assignment process.  
The correlation of Hα, Hβ, Cα, Cβ, and C’ crosspeaks with the preceding residue’s 
crosspeaks was carried out using CBCA(CO)NH, HNCACB, HBHA(CO)NH, 
HBHANH, HNCO data in the polyscope module.  The automatic strip matcher was used 
to predict polypeptide fragments that were then joined after intervening residues were 
assigned and fragments were confirmed by inspection of NOESY and TOCSY data.  Side 
chain assignments were then completed using the systemscope module.  Aromatic 
crosspeaks, Hδ and Hε were assigned using (HB)CB(CGCDCE)HE and 
(HB)CB(CGCD)HD spectra.  The remaining aromatic peaks were assigned using 2D 
homonuclear TOCSY and 2D homonuclear NOESY data.  The assigned 15N, 1H HSQC is 
shown in Figure 1. 
 
Structure of Itk SH3 
 
 For structure determination, NOE crosspeaks were picked in polyscope using the 
propose function of CARA.  To obtain a preliminary structure, a subset of NOEs was 
used for simulated annealing from an extended conformation.  This initial NOE subset 
consisted of NOEs for which resonance assignments were unambiguous and which were 
consistent with the general fold of the previously solved Itk SH3 structure 7.  Additional 
NOEs were then added as restraints in subsequent structure refinement.  NOEs that gave 
rise to violations during structure refinement were examined.  Those that were 
determined to be affected either by resonance overlap or proximity to the solvent signal 
were loosened or eliminated.   
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 Hydrogen bond, J-coupling, and torsion angle restraints were then added and a set 
of 200 structures were generated by simulated annealing from extended structures.  To 
incorporate RDC restraints, starting alignment tensor terms Da (axial symmetry) and R 
(rhombicity) were calculated via SVD (singular value decomposition) using the average 
minimized structure generated from the 20 lowest energy structures among the set of 200.  
Finally, 60 structures were generated with simulated annealing using the following 
restraints: NOEs, hydrogen bonds, J-couplings, torsion angles, and RDCs.  The 20 lowest 
energy structures based on bond, angle, improper, RDC, NOE, and torsion restraint 
energies (Figure 2b) were used to generate an average structure for the free Itk SH3 
domain (Figure 2a).  During the minimization, Da and R were allowed to vary, the final 
values for the average structure were -5.68 and 0.609 respectively. 
 The quality of the final murine Itk SH3 structure was evaluated using 
PROCHECK_NMR 17 and WHATCHECK 18. Ramachandran plot statistics in the core, 
allowed, generously allowed, and disallowed regions for residues in the average structure 
are 76.9%, 17.0%, 4.6%, and 1.5% respectively.  The average backbone RMSD (N, Cα, 
C’) is 0.55 Å and average heavy atom RMSD is 1.27 Å (Table 1).  All figures were 
created using PYMOL 19.  The Itk SH3 structure has the same secondary structural 
elements found in other SH3 domains including five β strands that form a β barrel and a 
short 310 helix at the C terminus (Figure 2). 
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Coordinates 
 
 The coordinates have been deposited in the Protein Data Bank (accession codes: 
2rn8, 2rna).  Complete resonance assignments have been deposited into BioMagResBank 
(accession code 11018). 
 
 
Discussion and Conclusions 
 
 The Itk SH3 domain was solved to high resolution using NMR spectroscopy as a 
first step in determining the structure of the binary complex between Itk SH3 and Itk 
SH2.  This Itk SH3 domain structure (Figure 2a & b) is a better model than the previous 
Itk PrSH3 structure for use in conjoined rigid body/torsion angle-simulated annealing 9.  
As expected, the overall folds of the free Itk SH3 domain and PrSH3 are similar yet the 
RMSD for backbone atoms (N, Cα, C’) between SH3 and PrSH3 for residues 173 
through 229 is 2.52 Å.  This can be compared to the corresponding backbone RMSD of 
1.44 Å between the free Itk SH3 domain solved here and the Btk SH3 domain (pdb: 
1awx) 20.  The larger RMSD between the free Itk SH3 domain structure and PrSH3 might 
therefore be significant.  The largest differences are localized to the N-terminal half of 
the β2 strand and the β1 strand of the SH3 domain (Figure 2c).  Indeed, such differences 
were previously noted between the structure of the free Btk SH3 domain and Itk PrSH3 
20.  
The presence of the extended N-terminal proline-rich region of PrSH3 is the 
likely explanation for the differences between the two Itk SH3 structures (and for 
differences observed in the comparison between Btk SH3 and Itk PrSH3 20).  
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Intramolecular interaction between the proline-rich region and the aromatic binding cleft 
of PrSH3 7; 8 appears to alter the conformation of the N-terminal region of the SH3 
domain (including the β1 strand and the RT loop) and the β2 strand.  The location of the 
observed structural differences are consistent with the fact that these elements are all 
close in space to the linker region that connects the proline-rich sequence and the N-
terminus of the SH3 domain (Figure 2c) suggesting that the intramolecular tether between 
SH3 domain and proline-rich ligand perturbs part of the SH3 structure.       
We next examined side chain conformations in the conserved SH3 domain 
binding cleft for both free Itk SH3 domain and PrSH3.  Three aromatic residues make 
direct contact to canonical proline ligands; Y180, Y225 and W208 (Itk numbering).  
There are discernable differences in the relative orientation of Y180 and Y225 between 
the free (structure solved here) and ligand bound (PrSH3) Itk SH3 structures.  The angle 
between these two tyrosines appears to widen to accommodate the proline motif (Figure 
3a).  Inspection of a number of other SH3 domains for which both free and ligand bound 
structures are available reveals similar changes in these two conserved tyrosines.  As 
shown in Figure 3b-d, the SH3 domains of Crk, Grb2, and Hck all show a similar trend in 
the position of Tyr 180 and 225 (Itk numbering) between free and ligand bound 
structures.  In all of these cases, the angle between the two tyrosine side chains is smaller 
for the free SH3 domain and widens slightly upon ligand binding.  For the Crk SH3 
domain (Figure 3b), it is notable that even for several different ligand bound structures 
the angle between the two tyrosine residues widens to a nearly identical extent upon 
ligand binding.  It should be noted however, that the small changes evident between these 
free and bound SH3 domain structures are not universally observed as demonstrated by 
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the SH3 structures of p40phox; ligand bound and unbound structures in that case overlay 
extremely well (Figure 3e).  Moreover, differences between structures that have been 
determined by NMR versus x-ray crystallography could contribute in part to the putative 
conformational changes and further systematic studies are needed to fully describe subtle 
SH3 structural changes that might occur on binding proline-rich ligands.    
With the high-resolution Itk SH3 domain structure now solved, NMR data 
acquired for the Itk SH3/SH2 complex can be more effectively analyzed to determine the 
molecular details of the non-classical interaction between the Itk SH2 and Itk SH3 
domains.  Additionally, this structure is more appropriate for comparisons with other SH3 
structures than the previously solved PrSH3 structure.   
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Figure Captions: 
Figure 1  
1H-15N HSQC spectrum of Itk SH3 at pH 7.4, 298˚K.  Backbone and side chain NH 
assignments are indicated using the one letter amino acid code and full length Itk 
numbering.  Side chain residues are labeled with Hε1 for tryptophans (W208 and W209), 
Hδ2 for asparagines (N232, N185, and N215) and Hε2 for glutamines (Q212, Q183, and 
Q188). 
 
Figure 2   
 Itk SH3 domain structure.  (a) Stereo view of the Itk SH3 average minimized structure.  
The five β strands that form the β barrel are colored in yellow while the loops are green.  
Aromatic residues located in the binding pocket: Y180, Y225, W208, Y182, and Y220, 
are colored in cyan.  (b) Ensemble generated from the superposition of the 20 lowest 
energy structures on the backbone atoms (Cα, C’, N) for residues spanning 173-229.  
Color scheme and side chains shown are as in (a).  (c)  Overlay of the Itk SH3 and PrSH3 
average minimized structures colored in black and grey, respectively.  Structural 
differences between Itk SH3 and PrSH3 are evident in the β1, β2 strands, and RT loop. 
The side chains of the proline-rich region (KPLPPTP) are shown for the PrSH3 structure.  
The different N- and C-termini for the two structures are labeled and the linker within 
PrSH3 is indicated. 
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Figure 3   
Superpositions of SH3 domain structures either bound to a proline-rich peptide ligand 
(colored black) or unbound (colored grey).  The bound and unbound structures for each 
SH3 domain were superimposed using all SH3 domain atoms.  Three aromatic residues 
within the SH3 binding pocket are depicted (Y180, Y225 and W208 for Itk) and labeled 
for each structure.  Residue labels correspond to the full length numbering for each 
protein.  For each bound structure the proline from the ligand that contacts Y180 and 
Y225 (Itk numbering) is indicated in red.  The pdb code for each free and bound structure 
is: (a)  Itk: this study (free), 1awj (bound); (b) c-Crk: 1m30 (free), 1bo7 (bound), 1cka 
(bound), 1ckb (bound); (c) Grb2: 1gfc (free), 1io6 (bound); (d) Hck: 4hck (free), 2oj2 
(bound); (e) p40phox: 1w6x (free), 1w70 (bound).  
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Table 1: Structural Statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a The variables i and j refer to residue numbers. 
b There are two restraints for each of 15 hydrogen bonds. 
 
 
Experimental Restraints  
Number of 
Restraints 
Total NOEs   1260 
 
Intra-
residuea |i-j|=0 657 
 Sequential   |i-j|=1 261 
 Medium  1<|i-j|<5 77 
 Long Range  |i-j|>5 265 
    
Backbone hydrogen bondsb  30 
cdih total   88 
 φ  8 
 ψ  24 
 ω  55 
J coupling   23 
Residual dipolar 
Coupling NH  27 
Total restraints   1428 
    
Restraint Statistics   
    
RMSD from standard geometry Deviation 
  Bonds(Å)  0.004 0.0005 
  Angles(deg)  0.508 0.017 
  Improper(deg)  0.401 0.023 
RMSD from experimental restraints 
  Distance(Å)  0.041 0.002 
  cdih(deg)  0.44 0.102 
    
Ramachandran Plot 
    
  Core  76.9 3.7 
  Allowed  17.0 3.6 
  Generously     
  allowed  
 
4.6 2.5 
  Disallowed  1.5 1.4 
Average RMSD Backbone N,Cα,C' 0.55Å 
  ItkSH3 Heavy atoms 1.27Å 
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Figure 2 
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Figure 3 
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CHAPTER 3.  MURINE ITK SH2 DOMAIN 
 
A collection of unpublished data 
 
Abstract: 
 
 The SH2 domain of the non-receptor tyrosine kinase, Itk, contains an intrinsic 
molecular switch that regulates binding affinity of its molecular targets.  In one 
conformational state, the SH2 domain binds the canonical phosphotyrosine containing 
peptides and in the other conformational state, it binds the SH3 domain through a non-
canonical interaction.  The structure of this non-canonical interaction is important to the 
understanding Itk self-association in the full-length molecule.  In an effort toward solving 
the structure of the Itk SH2/SH3 complex, the solution structure of the unbound Itk SH2 
domain was refined using RDC restraints.  The RDC refined structure allows for the 
comparison with the previously solved SH2 domain structure.   
 
Introduction: 
 
Post-translational modification has an integral role in regulating cell signaling 
achieved through the covalent addition and chemical modification of proteins that alter 
the binding affinity to downstream protein targets.  Recently however, a new mechanism 
for protein regulation in the cell is emerging that requires no chemical or covalent 
modification.  Peptidyl prolyl cis/trans isomerization is an intrinsic conformational switch 
found in a growing number of protein structures 1; 2; 3; 4; 5; 6; 7.  
Interleukin-2 tyrosine kinase contains a proline that undergoes proline 
isomerization and this molecular switch has been shown to regulate Itk signaling 
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(unpublished data of L. Min and W. Wu).  Itk is a five-domain containing non-receptor 
tyrosine kinase important in proper T-cell signaling and immune response to T-cell 
receptor stimulation8.  The Itk SH2 domain contains a proline imide bond between 
residues Asn286 and Pro287 that undergoes cis/trans isomerization resulting in a large 
conformational change in the CD loop.  This conformational change affects the local 
chemical environment for close to one third of the residues found in the SH2 domain as 
observed by the appearance of double resonances in the 1H 15N HSQC (Figure 2) 9.  The 
SH2 population in which the proline imide bond is found to be cis will be referred to as 
the cis SH2 conformer and likewise the SH2 population in which the proline imide bond 
is found to be trans will be referred to as the trans SH2 conformer.  The molecular switch 
that interconverts between the two conformers of the Itk SH2 structure regulates the 
binding affinity of the Itk SH2 domain for the classical phosphotyrosine containing 
peptide and a novel interaction with the Itk SH3 domain 10.   
NMR data on the Itk SH2 domain was recently re-acquired using a higher field 
strength magnet with cryoprobe as one of six samples required to solve the structure for 
the novel interaction between the Itk SH2 and Itk SH3 domains.  Although the structures 
of the cis and trans conformers of Itk SH2 were solved in 2002 9, solving the structure of 
the Itk SH3/SH2 interaction relies on the conjoined rigid body/torsion angle-simulated 
annealing method in which the starting structures need to be of high structural quality 11.  
To obtain the highest quality structure possible, the newly acquired data on the Itk SH2 
cis conformer included information from a relatively new technique, residual dipolar 
coupling (RDC) information, which is now commonly used to refine NMR structures to 
high resolution 12.  Thus, the high-resolution refined solution structure of the unbound Itk 
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SH2 cis conformer (Figure 1a) is presented here as the second step toward solving the 
structure of the Itk SH3/SH2 complex. 
 
 
Methods and results: 
 
NMR sample preparation 
 
 Protein expression and purification were performed as described previously 13.  
The NMR sample consisted of 1.5 mM 13C, 15N labeled Itk SH2 domain, 50 mM NaPO4, 
75 mM NaCl, 2 mM dithiothreitol (DTT), 5% D2O and 0.02% (w/v) NaN3 at pH 7.4.  
 
NMR Spectroscopy 
 
 All NMR spectra were collected at 298 K on a Bruker AVII 700 spectrometer 
equipped with a 5mm HCN z-gradient cryoprobe operating at 700.133 MHz 1H 
frequency.  Chemical shift assignments were elucidated from double and triple resonance 
experiments: CBCA(CO)NH, HNCACB, HBHA(CO)NH, HBHANH, HNCO, 
(HB)CB(CGCDCE)HE, (HB)CB(CGCD)HD, and HCCH-TOCSY, along with a 3D 15N-
edited TOCSY and 2D homonuclear TOCSY.  NOE correlations were obtained from a 
2D homonuclear NOESY, 3D 13C-edited aliphatic NOESY, 3D 13C-edited aromatic 
NOESY, and 3D 15N-edited NOESY spectra.  All NOESY experiments were acquired 
with a mixing time of 100 ms.  
 IPAP 1H-15N correlation experiments were performed to measure residual dipolar 
coupling constants.  DNH values were determined from the difference between splittings 
recorded in anisotropic (J+D) and isotropic (J) media. Weak anisotropic alignment was 
achieved through the addition of 8 mg mL-1 of Pf1 phage 14; 15  
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Backbone torsion angle (φ, ψ and ω) data were obtained from 1HN, 15N, 1Hα, 
13CO and 13Cβ chemical shifts using PREDITOR 16.   Only those angles with a 
confidence greater than or equal to 0.5 were included.  J coupling phi restraints gathered 
from J-coupling data were given precedence and the corresponding phi angles obtained 
from PREDITOR were excluded. 
 Hydrogen bond restraints were used from the previously determined structural 
restraints identified through deuterium exchange experiments 9.  Two structural restraints 
were added in Xplor-NIH for each hydrogen bond: one restraint between the donor 
hydrogen and acceptor oxygen (1.2-1.5Å) and one restraint between the donor nitrogen 
and acceptor oxygen (2.2-2.5 Å).  All spectra were processed using TOPSPIN 1.3 and 
analyzed with CARA (Computer Aided Resonance Assignment) for chemical shift and 
NOE assignments 17.   
 
Resonance assignments for Itk SH2 domain 
 
The correlation of Hα, Hβ, Cα, Cβ, and C’ crosspeaks with the preceding 
residue’s crosspeaks was carried out using CBCA(CO)NH, HNCACB, HBHA(CO)NH, 
HBHANH, HNCO data in the polyscope module of CARA.  The automatic strip matcher 
was used to predict polypeptide fragments that were then joined after intervening residues 
were assigned and fragments were confirmed by inspection of NOESY and TOCSY data.  
Side chain assignments were then completed using the systemscope module.  Aromatic 
crosspeaks, Hδ and Hε were assigned using (HB)CB(CGCDCE)HE and 
(HB)CB(CGCD)HD spectra.  The remaining aromatic peaks were assigned using 2D 
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homonuclear TOCSY and 2D homonuclear NOESY data.  The assigned 15N, 1H HSQC 18 
is shown in Figure 2. 
 
Structure of Itk SH2 
 
 For structure determination, NOE crosspeaks from the previous structure 
determination were verified and additional peaks were picked in polyscope using the 
propose function of CARA.  NOEs that gave rise to violations during structure 
refinement were examined.  Those determined to be affected by either resonance overlap 
or proximity to the solvent signal were loosened or eliminated.  The starting alignment 
tensor terms Da (axial symmetry) and R (rhombicity) for RDC restraints were calculated 
using a grid search method in Xplor-NIH on the average minimized structure generated 
for the SH2 domain without RDC restraints.  Sixty structures were generated using 
simulated annealing and the following restraints: NOEs, hydrogen bonds, J-couplings, 
torsion angles, and RDCs.  The ensemble structure was created from the 20 lowest energy 
structures based on bond, angle, improper, RDC, NOE, and torsion restraint energies.  
The average minimized structure was generated from this ensemble (Figure 1b).  
 The refined cis conformer of the Itk SH2 domain is well defined.  The quality of 
the structure was evaluated using PROCHECK_NMR 19 and WHATCHECK 20.  
Ramachandran plot statistics in the core, allowed, generously allowed, and disallowed 
regions for residues in the average structure are 77.9%, 12.6%, 7.4%, and 2.1% 
respectively.  The average backbone RMSD (N, Ca, C0) is 0.89 Å and average heavy 
atom RMSD is 1.6 Å (Table 1).  All figures were created using PyMOL 21.   
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Discussion and Conclusions 
 
The cis conformer of the Itk SH2 domain was refined to high resolution using 
NMR spectroscopy as the second step in determining the binary complex between Itk 
SH3 and Itk SH2 domains.  The quality of the Itk SH2 cis conformer structure was 
improved by the addition of RDC restraints minimized in Xplor-NIH (version 2.19) 22.  
This Itk SH2 cis conformer structure is a better structure than the previously solved 
unbound structure 9 (pdbcode 1LUK) for use in conjoined rigid-body/torsion angle-
simulated annealing.  As expected, the overall secondary structural elements found in the 
refined cis conformer structure of the Itk SH2 domain is consistent with the general fold 
for SH2 domains: a three-strand anti-parallel β sheet sandwiched between two alpha 
helices.  A comparison between the previously solved SH2 structure (pdbcode 1LUK) 
and the RDC refined SH2 structure solved here shows minor differences in flexible loop 
regions as is expected from average structures determined by NMR (Figure 1c).  The 
backbone (CA, C’ and N) RMSD difference between the two structures is 1.54 Å.  The 
most notable improvement in the structure was seen in the overall backbone 
conformation.  In the Ramachandran plot statistics, there was a 13% improvement in 
residues found in both the core and allowed regions and a 1% improvement in residues 
found in both the generously allowed and disallowed regions.  
One purpose in recollecting the data on the Itk SH2 sample is to make 
comparisons between the unbound data and the refined structure of the unbound Itk SH2 
cis conformer with bound data and the structure of the Itk SH2 cis conformer bound to 
the Itk SH3 domain respectively, which are described in detail in Chapter 4.  The 
acquired data can also be analyzed to refine the Itk SH2 trans conformer completing the 
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NMR refinement of the Itk SH2 structure and providing a better NMR structure to 
compare to the recently solved crystal structure of the Itk SH2 domain (unpublished 
data).   
 
Figure Captions: 
Figure 1 
Itk SH2 domain structure.  (a) Stereo view of the Itk SH2 average minimized structure.   
The three β strands are colored in yellow sandwiched between two α helices in red and 
the loops are green. The isomerizing proline is colored blue. (b) Ensemble generated 
from the superposition of the 20 lowest energy structures on the backbone atoms (Cα, C’, 
N).  Color scheme and side chains shown are the same as in (a).  (c)  Overlay of the Itk 
SH2 (1LUK) and the RDC refined average minimized structures colored in grey and 
green, respectively.  Minor structural differences between these structures are evident in 
the CD, BG, and EF loops. 
 
Figure 2  
1H-15N HSQC spectrum of Itk SH2 at pH 7.4, 298˚K.  Backbone and side chain NH 
assignments are indicated using the one letter amino acid code and full length Itk 
numbering.  Side chain residues are labeled with Hε1 for the tryptophan (W239), Hδ2 for 
asparagines (N232, N233, N241, N286, N298, and N325) and Hε2 for glutamines (Q320 
and Q323). 
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Table 1: Structural Statistics  
 
Experimental Restraints 
  
SH2 
(1LUK) 
SH2  
(RDC refined) 
NOEs   2324 2340 
CDIH   127 127 
RDC NH 0 32 
Total   2451 2499 
Structures Calculated    200 60 
ensemble   20 20 
        
Ramachandran Plot 
percentage found in       
Core   64.2 77.9 
Allowed   26.3 12.6 
Generously Allowed   6.3 7.4 
Disallowed   3.2 2.1 
Average RMSD in Å    
  CA,C,N 0.71 0.89 
  not hydrogen 1.14 1.6 
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Figure 1 
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Figure 2 
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CHAPTER 4.  PROLINE ISOMERIZATION PREORGANIZES THE 
ITK SH2 DOMAIN FOR BINDING THE ITK SH3 DOMAIN 
 
A paper published in the Journal of Molecular Biology, (2009) 387, 726-743. 
Andrew Severin1, Raji E. Joseph, Scott Boyken, D. Bruce Fulton, Amy H. Andreotti* 
 
Summary 
 We report here the NMR derived structure of the binary complex formed by the 
Itk SH3 and SH2 domains.  The interaction is independent of both a phosphotyrosine 
motif and a proline-rich sequence; the classical targets of the SH2 and SH3 domain, 
respectively.  The Itk SH3/SH2 structure reveals the molecular details of this non-
classical interaction and provides a clear picture for how the previously described prolyl 
cis/trans isomerization present in the Itk SH2 domain mediates SH3 binding. The higher 
affinity cis SH2 conformer is pre-organized to form a hydrophobic interface with the SH3 
domain.  The structure also provides insight into how autophosphorylation in the Itk 
SH3 domain might increase the affinity of the intermolecular SH3/SH2 interaction.  
Finally, we can compare this Itk complex with other examples of SH3 and SH2 domains 
engaging their ligands in a non-classical manner.  These small binding domains exhibit a 
surprising level of diversity in their binding repertoires.  
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Introduction 
The non-receptor Interleukin-2 tyrosine kinase (Itk) is an important 
immunological protein involved in regulating T-cell receptor (TCR) response to antigen 
stimulation 1, actin cytoskeletal rearrangement 2; 3 and more recently, Itk has been 
implicated in the HIV replication pathway 4.  Itk and the related Tec family kinases (Btk, 
Txk, Tec and Bmx) all contain the common SH3-SH2-Kinase domain structure and, with 
the exception of Txk, also contain an N-terminal Pleckstrin homology (PH) domain 1.   
The Src homology 2 and Src homology 3 (SH2 and SH3) domains are well characterized 
protein binding domains involved in protein regulation, substrate recognition, and cell 
signaling 5. Classical ligands for the SH3 domain consist of proline-rich sequences 6, and 
SH2 domains typically bind phosphotyrosine (pY)-containing motifs 5; 7; 8.  While these 
canonical sequences constitute the most well understood targets of the SH3 and SH2 
domains, alternative binding interactions for these modular domains are emerging 9; 10; 11; 
12; 13; 14; 15; 16; 17; 18; 19; 20; 21; 22; 23; 24.  
In this vein, the SH3 and SH2 domains of Itk participate in both classical ligand 
binding 25; 26 and non-classical interactions 27.  We previously reported solution NMR 
work that defined a specific intermolecular interaction between the SH3 and SH2 
domains of Itk 27.  In that work, intermolecular self-association of the Itk dual domain 
fragment, SH3-SH2, is described and interaction surfaces on both domains were mapped 
using chemical shift perturbations and differential isotopic labeling.  Chemical shift 
mapping indicated that the SH3/SH2 interaction involves the classical ligand-binding 
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cleft of the Itk SH3 domain and a surface that only partially overlaps the canonical 
ligand-binding surface of the Itk SH2 domain.  The interaction is independent of 
phosphotyrosine, and the proline-rich sequence that defines classical SH3 targets is not 
present within the Itk SH2 domain.  Thus, the Itk SH3/SH2 interaction represents an 
alternative mode of binding for each of these well-studied domains.   
Additional molecular details for the Itk SH3/SH2 interaction emerged following 
complete structure determination of the Itk SH2 domain 28.  The Itk SH2 domain contains 
a rather unique residue, Pro 287, which interconverts between the cis and trans imide 
bond conformers in solution.  This exchange process leads to two distinct structures of 
the Itk SH2 domain since cis/trans isomerization about the Asn 286-Pro 287 imide bond 
induces conformational differences across one-third of the domain surface.  As a result, 
the cis and trans imide bond containing Itk SH2 conformers (also referred to as cis SH2 
or trans SH2) exhibit different ligand binding properties.  The classical phosphotyrosine 
ligand binds preferentially to the trans imide bond containing SH2 domain and the Itk 
SH3 domain binds with greater affinity to the cis imide bond containing SH2 domain 29.  
The structure of a classical phosphotyrosine containing peptide ligand bound to the trans 
Itk SH2 domain has been solved 26 providing insight into why this canonical SH2 ligand 
prefers the trans imide bond containing SH2 conformer over cis.  The structure of the Itk 
SH3 domain bound to the cis imide bond containing conformer of the Itk SH2 domain 
reported here now provides a more complete picture of proline-driven molecular 
recognition within this small domain.  
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In due course, the intermolecular Itk SH3/SH2 interaction must be understood in 
the context of the full length Itk protein.  In addition to the intermolecular interaction 
between SH3-SH2 fragments of Itk 27, the Itk PH domain also interacts with itself in an 
intermolecular fashion 30 and the structure of the Btk PH domain reveals a dimeric 
arrangement 31.  Moreover, the other Tec family kinases; Btk, Tec and Txk, exhibit 
intermolecular self-association of their non-catalytic regulatory domains 32; 33; 34; 35. In the 
context of the intermolecular interactions reported for these domain fragments, it is 
notable that full length Itk readily co-immunoprecipitates with itself 30; 36 and Itk 
clustering at the T cell receptor has been observed upon T cell activation 37.  We therefore 
hypothesize that the Itk regulatory domains mediate a functionally relevant self-
association of full length Itk.  The structure of the Itk SH3/SH2 complex reported here is 
a step toward gaining an understanding of the molecular details of Itk intermolecular self-
association.  Such information should ultimately translate into a better understanding of 
how these interactions mediate Itk signaling in the T cell.   
 
Results 
NMR solution studies on the dual domain SH3-SH2 fragment of Itk indicated an 
intermolecular interaction that is dependent on the aromatic binding cleft of the SH3 
domain (mutation of the conserved W208 in the Itk SH3 domain abolishes the 
intermolecular interaction between SH3-SH2 fragments) 27.  In this early work 27, the 
SH3-SH2 containing fragment of Itk was considered primarily dimeric.  This conclusion 
was based on measured NMR linewidths and NMR diffusion data both of which would 
have been weighted toward the monomer and dimer species rather than larger aggregates 
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given the inherent line broadening and disappearance of the NMR signal with increasing 
molecular weight.  At the time, it was noted that the quality of NMR spectra acquired for 
samples containing the Itk SH3-SH2 dual domain was poor, likely due to exchange 
broadening.  We have subsequently revisited the aggregation state of the Itk SH3-SH2 
fragment using native gel electrophoresis.  As shown in Figure 1a (lane 2), a native gel 
corresponding to the wild type Itk SH3-SH2 fragment exhibits multiple bands consistent 
with the notion that SH3-SH2 intermolecular self-association leads to formation of 
multiple aggregated species.  In a similar manner, full length Itk also produces multiple 
bands on a native gel (data not shown) suggesting that the intermolecular oligomerization 
of the SH3-SH2 dual domain fragment is retained in the full-length molecule.  Thus, 
formation of multiple oligomerized species is consistent with NMR data for the Itk SH3-
SH2 dual domain fragment that are adversely affected by both exchange broadening and 
the presence of high molecular weight species.  Indeed, while NMR spectra of SH3-SH2 
are sufficient for chemical shift mapping, further NMR work to solve the structure of the 
Itk SH3-SH2 fragment posed significant challenges due to poor spectral quality.  
We found, however, that the intermolecular interaction can be recapitulated by 
expressing the single domains; purified Itk SH2 can be titrated into labeled Itk SH3 and 
chemical shift changes in the SH3 domain map the same surface as that of the dual 
domain interaction 27.  Likewise, purified Itk SH3 can be titrated into labeled Itk SH2 to 
map the SH2 side of the interaction.  The quality of the NMR spectra in these single 
domain titrations is superior to that acquired for the dual domain.  We therefore 
proceeded with structure determination of the binary complex formed by the singly 
expressed Itk SH3 and SH2 domains. 
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Two different strategies were initially employed to solve the structure of the Itk 
SH3/SH2 complex.  We began by screening conditions for crystallography yet found 
none that produced crystals of the complex; likely due to the relatively low affinity of the 
interaction (the Kd for the SH3/SH2 interaction is 670 µM 29).  We therefore focused our 
efforts on structure determination by NMR.    There has been great success in 
determining weak protein-protein interactions using conjoined rigid body/torsion angle 
simulated annealing 38; 39.  In fact, the structure of the extremely weak (~3000 µM) 
protein-protein interaction between Nck-2 SH3-3 and PINCH-1 LIM4 was recently 
solved using this technique 21.  This experimental method takes advantage of orientation 
restraints obtained from residual dipolar coupling (RDC) experiments and short distance 
restraints obtained from intermolecular NOEs. In addition, using starting structures for 
the individual domains that do not undergo a large conformational changes upon binding 
allows the calculation to be simplified by holding the atoms in the initial structures rigid 
but allowing for rotation and translation of the structures to minimize distance and 
orientation restraints.  After this initial minimization, side chain residues at the interaction 
interface are given their full torsional degrees of freedom along with the rotational and 
translational degrees of freedom of the rigid bodies and the energy function is minimized 
to generate a final complex structure. 
To solve the structure of the binary complex, distance restraints, orientation 
restraints, and starting structures of the individual Itk SH3 and SH2 domains were 
required.  Distance restraints are obtained from the identification and assignment of 
intermolecular NOE restraints.  Orientation restraints are obtained from RDC 
experiments that depend on the identification of one or several inert alignment media. 
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Starting structures of the individual domains are obtained from selectively labeled NMR 
data on the bound binary complex.  Additionally, we made use of the recently solved 
structure of the free Itk SH3 domain 40 and used RDCs to refine the previously solved 
structure of the unbound cis SH2 domain 28.  These unbound domain structures permitted 
direct comparisons between free and bound domains upon completion of the SH3/SH2 
complex structure.  
Two NMR samples containing 15N/13C labeled SH2 alone or 15N/13C labeled SH3 
alone were prepared (Table 1-1, 1-2).  NMR samples containing the binary complex 
required special consideration during preparation.  Based on previous experience with the 
Itk SH2 domain, a protein concentration above 5 mM is unstable due to precipitation over 
a short period of time.  To avoid complications due to sample instability, two samples 
were generated containing 15N/13C labeled SH3 with reasonable excess unlabeled SH2 
and 15N/13C labeled SH2 with the same excess unlabeled SH3 (Table 1-5, 1-6).  This ratio 
of labeled to unlabeled protein resulted in a stable, labeled domain that was 77% bound 
as calculated following previously published methods 34.   
To assign intermolecular NOE restraints, two additional NMR samples containing 
unlabeled SH2 with excess 15N/13C labeled SH3 and unlabeled SH3 with excess 15N/13C 
labeled SH2 were generated (Table 1-3, 1-4).  For these samples, the ratio of labeled to 
unlabeled protein gave a labeled sample that was 35% bound.  Thus, a total of six 
samples were generated for NMR data acquisition: unbound SH3 (15N/13C labeled), 
unbound SH2 (15N/13C labeled), and two samples each of 35% and 77% bound with 
either the SH3 or SH2 domain carrying the 15N/13C isotopic label (Table 1). Due to fast 
exchange the chemical shifts for a given atom differed in the 0%, 35% and 77% bound 
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samples. The 35% and 77% bound samples provided complementary information that 
allowed NOESY cross peaks to be assigned. For example, the proton chemical shifts of 
unlabeled SH2 in sample 3 (Table 1-3) are identical to the proton chemical shifts of 
labeled SH2 in sample 6 (Table 1-6).  
While the majority of resonances in the NMR spectra of the SH3/SH2 mixture are 
in the fast exchange regime, we find that exchange broadening for the samples containing 
77% bound protein prohibited observation of many of the crosspeaks thus hampering 
efforts to identify and assign intermolecular NOEs.  A direct comparison of the NOESY 
data of W208 for the unbound, 35% bound, and 77% bound samples (Figure 1b) show 
the extent of line broadening due to exchange.  Exchange broadening is evident in the 
NOESY strip for W208HZ2: the NOE between L329HA and W208HZ2 is clearly visible 
in the 35% bound sample but not seen in the 77% bound sample.  In addition, the NOE 
between W208HZ2 and R332HG2 is broadened yet still visible in the 77% bound 
sample.  For some NOEs, we find little effect from exchange broadening; for example, 
the NOE between W208HD1 and L329HA is similar for the 35% and 77% bound 
samples.  Overall, the NOESY data acquired for unbound and 35% bound samples 
showed sufficiently narrow linewidths to permit complete identification and resonance 
assignment of intra- and intermolecular NOEs. We therefore obtained distance restraints 
for structure calculations of the bound SH3 and SH2 domains as well as intermolecular 
NOE restraints using data from the 35% bound sample and, when linewidths permitted, 
the 77% bound sample.  The NOESY data obtained from free SH3 or SH2 domain 
provided a useful comparative tool for the identification of intermolecular NOEs defining 
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the SH3/SH2 interface since intermolecular NOEs will be absent in these datasets (Figure 
1b). 
To acquire orientation restraints from RDC experiments, a medium that induces 
weak alignment in the sample but does not otherwise interact with the protein complex of 
interest is needed.  Due to differences in the isoelectric points for the two domains (4.3 
versus 8.8, respectively for the Itk SH3 and Itk SH2 domains) and the large hydrophobic 
binding pocket on the SH3 domain, it was difficult to identify an alignment media that 
did not interact strongly with either the SH3 or SH2 domain.  We found that despite its 
highly negative charge, Pf1 phage can be used in low concentration (8mg/ml) as an 
alignment media for the positively charged SH2 domain 41, the SH3 domain, and the 
binary complex.  
To obtain orientation restraints, we used residual dipolar coupling (RDC) data 
acquired from the fractionally bound NMR samples described in Table 1 to extrapolate 
RDC values for the structure calculation.  The dipolar coupling values, DCAHA and DNH, 
for all structure calculations were determined from the difference between one bond scalar 
couplings recorded in a phage containing weakly aligned sample (giving J+D) and a no-
phage non-aligned sample (giving J).  The couplings for the completely bound complex, 
Dbound, could not be measured directly and instead were calculated from the population 
weighted average couplings in the 35% and 77% bound samples using Equation 1 
providing two estimates of the fully bound value42.  The value of Dbound used in structural 
calculation was the average of the corresponding values calculated from the 35% and 77%  
bound datasets.  
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The binary complex structure was then calculated from the NOE-derived 
restraints and 58 orientation restraints derived from RDC experiments.  The lowest 
energy structure obtained from conjoined rigid body/torsion angle simulated annealing 
was further refined using traditional non-rigid simulated annealing protocols 38; 43; 44; 45. 
 
Structural overview of the Itk SH3/SH2 binary complex 
The structure of the binary SH3/SH2 complex is well defined (Figure 2 and Table 
2).  Backbone overlays of the 20 lowest energy structures show good convergence 
(Figure 2a) with a backbone RMSD (N, Cα, C’) of 0.68 Å and an overall heavy atom 
RMSD of 1.28 Å.   The individual domains in the complex exhibit their characteristic 
folds (Figure 2b; Figure 1S in Supplementary Material).  The bound Itk SH2 domain 
contains a central, three-strand anti-parallel beta sheet sandwiched between two alpha 
helices and has a backbone RMSD (including all loops) from the refined unbound cis 
SH2 structure of 1.28Å 28.  The bound Itk SH3 domain contains two anti-parallel beta 
sheets that wrap around each other to form a beta barrel and has a backbone RMSD from 
the unbound SH3 structure of 0.98Å 40.  In each case the RMSD was calculated between 
energy minimized average structures. The C-terminus of the SH3 domain and the N-
terminus of the SH2 domain (the termini covalently linking each domain to its adjacent 
domain in the SH3-SH2 dual domain fragment) protrude from opposite sides of the 
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SH3/SH2 intermolecular complex (Figure 3a).  The structure reveals that the Itk SH2 
domain binds to the conserved SH3 binding pocket and the Itk SH3 domain interacts with 
the pY+3 binding pocket and CD loop of the Itk SH2 domain, consistent with previously 
reported chemical shift mapping and ligand competition data 27.  The interaction between 
Itk SH3 and SH2 domains does not involve the pY binding pocket on the SH2 domain 
(Figure 3a). 
In the surface rendering of the SH3/SH2 complex (Figure 3b) it is evident that the 
larger SH2 domain clasps the edges of the SH3 domain binding groove.  The CD and EF 
loops of the SH2 domain resemble the fingers and thumb, respectively of a hand clasping 
the ball shaped SH3 domain (Figure 3b).  The BG loop lies in the central, back part of the 
interface in the view shown in Figure 3b.  The binding interface between the Itk SH3 and 
SH2 domains has a total buried surface area of 1430 Å2 ± 80.  This is larger than the 
buried surface area reported for the ultra weak protein-protein interaction described by 
Vaynberg et al. (~480 Å2) and is similar to the mean buried surface area of nine 
previously reported weak protein complexes (1386 Å2 ± 214) 46 as determined by the 
protein-protein interface comparison server: PROTORP 47.  
At the outset of this work, we wished to understand why the cis imide bond 
containing SH2 conformer exhibits a greater affinity for the Itk SH3 domain than does 
the trans conformer 29.  Interestingly, the structure of the SH3/SH2 complex shows that 
Pro 287 itself does not make direct contact with the Itk SH3 domain (Figure 4a).  The 
structural differences between the cis and trans conformers of the unbound Itk SH2 
domain are largest in the CD loop and backbone 15N relaxation data for the cis and trans 
conformers showed that the CD loop in the cis conformer is more rigid than that in the 
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trans conformer 28. The CD loop in the cis imide bond containing SH2 conformer appears 
pre-organized to make several contacts to a hydrophobic patch on the SH3 domain.  
Three hydrophobic side chains on the SH2 domain CD loop, A281, I282 and I283, pack 
into a hydrophobic cluster on the SH3 domain surface comprised of the conserved 
aromatic residues, Y180 and Y225, as well as L179, C194 and V227 (Figure 4b).   
Superposition of the trans imide bond containing SH2 conformer with the corresponding 
cis SH2 domain in the SH3/SH2 complex demonstrates how these contacts are lost on 
isomerization of the 286-287 imide bond to the trans configuration.  The different CD 
loop conformation in the trans SH2 domain results in a decrease of approximately 25% 
of the total buried surface area of the SH3/SH2 complex and concomitant loss of 
hydrophobic contacts between the SH2 and SH3 domains; the side chains of A281, I282 
and I283 are solvent exposed and considerably more flexible in the trans conformer28 
(Figure 4).   
Of the SH2 residues at the SH3/SH2 interface, the CD loop residues (A281, I282 
and I283) lie farthest from the canonical phospholigand binding pockets of the SH2 
domain, make extensive contacts to the SH3 domain across the interface, and as 
previously reported, I282 in particular serves to stabilize the cis SH2 domain28. For these 
reasons we explored whether a mutation in this region of the Itk SH2 domain might 
effectively abolish the intermolecular SH3/SH2 interaction without adversely affecting 
phospholigand binding.  Using the singly expressed domains, we find that the mutant Itk 
SH2(I282A) domain causes no chemical shift perturbations when titrated into an 15N 
labeled sample of Itk SH3 (data not shown) indicating no detectable interaction between 
SH3 and SH2(I282A).  This result was then followed by incorporation of the I282A 
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mutation into the Itk dual domain fragment (SH3-SH2(I282A)) and examination by 
native gel electrophoresis (Fig. 1a, lane 4).  Unlike the wild type SH3-SH2 dual domain 
(Fig. 1a, lane 2), the single I282A point mutant in the Itk SH3/SH2 dual domain abolishes 
intermolecular self-association giving rise to a single band on the native gel.   
For the I282A mutation to be a useful tool in disrupting Itk self-association for 
further functional studies, it must have a negligible effect on the phospholigand binding 
function of the Itk SH2 domain.  We therefore measured the binding affinity of the Itk 
SH2(I282A) mutant to a classical phosphotyrosine containing ligand.  Titration of a 
phosphopeptide derived from Slp76 (Ac-ADpYEPP-NH2) into 15N labeled SH2(I282A) 
was carried out to determine the dissociation constant for the mutant 
SH2/phosphopeptide interaction as previously described29.  Unexpectedly, we found that 
mutation of isoleucine 282 to alanine in the SH2 domain caused a decrease in 
phosphopeptide binding affinity.  The Kd for phosphopeptide binding to the SH2(I282A) 
mutant is 1.0 ± 0.2 mM compared to a Kd of 0.25 ± 0.2 mM for binding of the same 
phosphopeptide to the wild type SH2 domain 29. 
The structure of the Itk SH2 domain bound to this phosphopeptide ligand has 
been solved previously 26 and Ile 282 is, as mentioned above, located far from the peptide 
binding site.  We presume therefore that altered domain dynamics rather than loss of 
direct contacts to the ligand might be the source of the observed affinity loss.  Whatever 
the cause, this result underscores an important conceptual point regarding functional 
probing of Itk self-association.  Targeted functional experiments to elucidate the 
significance of full length Itk self-association will require a minimal set of mutations that 
selectively alter/abolish intermolecular Itk self-association but have no measurable effect 
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on the classical ligand binding activities of each domain.  Such mutations would allow 
for activity assays or in vivo experiments using Itk variants that do not exhibit 
intermolecular clustering but retain all other functions, in particular the protein-protein 
interactions mediated by the various domains of Itk during signaling.  Thus, while the 
I282A mutation appears to abolish intermolecular self-association of the dual domain 
SH3-SH2 fragment (Fig. 1a), its negative effect on classical phospholigand binding 
means that this mutation cannot be incorporated into full length Itk to study self-
association in a physiological context without also adversely affecting other signaling 
functions.  The structure of the Itk SH3/SH2 complex solved here must therefore be 
probed more extensively to identify appropriately selective mutational tools for 
biochemical and cell biological experiments aimed at elucidating the functional 
significance of full length Itk self-association. 
 
Comparison of Itk SH3/SH2 and the SH3/proline-rich ligand interfaces 
In addition to hydrophobic contacts between the CD loop of the cis SH2 domain 
at one end of the SH3 binding cleft, the structure of the Itk SH3/SH2 complex also 
reveals some similarities to classical SH3 mediated proline-rich ligand binding.  The 
well-characterized SH3 binding surface consists of three shallow pockets (denoted I, II 
and III) that typically contact three distinct regions of a proline-rich peptide ligand 6.  
SH3 binding clefts I and II contact the two aliphatic-proline dipeptide units of the 
classical proline-rich ligand.  In binding groove III, a conserved acidic site (E189 in Itk 
SH3) forms a salt bridge with a basic residue on the peptide ligand (Figure 5a).   
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Side chains on the BG and EF loops of the Itk SH2 domain point into two of the 
Itk SH3 binding clefts that are separated by W208 (Figure 5b).  Contacts in the complex 
structure between Itk SH2 and the Itk SH3 domain in this region are consistent with 
earlier analysis showing the importance of the W208 side chain.   Mutation of W208 in 
the Itk SH3 domain abolishes both proline ligand binding 25 and the interaction with the 
Itk SH2 domain 27.  To compare the side chain contacts between SH3 and SH2 domain to 
classical proline-rich ligand recognition by the SH3 domain, the SH3 domain of the Itk 
SH3/SH2 complex is superimposed with the Itk SH3/peptide ligand complex solved 
previously25.  To visualize the interface more clearly, the Itk SH2 domain is removed 
with the exception of the EF, BG and CD loop residues (K309, R332, V330, T279 and 
A281) that point toward the Itk SH3 domain. Using this superposition, the similarities 
and differences between the proline-rich ligand (KPLPPTP) and the SH2 domain ligand 
for the Itk SH3 domain are illustrated in Figure 5c.   
The most notable similarity is the correspondence between SH2 residue K309 in 
the EF loop and the lysine residue of the proline-rich peptide ligand that contacts binding 
pocket III.  In binding pocket II, V330 in the SH2 BG loop coincides in space to the 
similarly large, hydrophobic leucine of the proline-rich peptide.  In a departure from the 
proline-rich peptide sequence, the other SH2 residue on the BG loop that makes contact 
to binding pocket II is not proline, as found in a classical proline-rich ligand, but rather 
R332.  The long arginine sidechain appears to extend along the surface of the SH3 
domain with the guanidinium headgroup of R332 possibly forming a hydrogen bond with 
the side chain amide group of Asn 185 on the SH3 domain. Indeed, the dissociation 
constant measured for the Itk SH2(R332A) mutant and wild type SH3 domain is 1.8 mM, 
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three fold weaker than the wild type interaction. In binding pocket I, the SH2 ligand 
deviates from the proline-rich peptide as the CD loop (including residues T279 and 
A281) veers slightly out of the well-defined SH3 cleft to participate in the hydrophobic 
contacts depicted in Figure 4.  Nevertheless, it is interesting to note that the SH2 ligand 
presents a threonine (T279) at a position that might mimic the threonine of the peptide 
ligand that contacts cleft I (Fig. 5c).  
Since the electrostatic interaction between a basic residue of the prototypical 
proline-rich peptide and the conserved acidic site on the SH3 surface (E189 in Itk SH3) 
plays an established role in mediating proline ligand binding 48; 49; 50, we tested the 
contribution to binding affinity of both E189 and the basic side chain, K309 of SH2, that 
appears to mimic the canonical peptide.  Curve fitting analysis of NMR data 34 obtained 
from the titration of unlabeled Itk SH2 domain into 15N labeled Itk SH3 domain was 
carried out to measure the affinities of several SH3 and SH2 mutants (Figure 5d).  Three 
different combinations of mutants were tested and compared to the wild type SH3/SH2 
interaction (Kd = 0.67 mM).  First, E189 in the SH3 domain was mutated to glutamine 
(SH3(E189Q)) to test the putative role of this conserved negative charge on the SH3 
domain surface.  Consistent with the structure of the SH3/SH2 complex, we find that the 
affinity of the Itk SH2 domain for the SH3(E189Q) mutant drops significantly (Kd = 2.05 
mM).  Likewise, mutation of K309 in the SH2 domain, predicted from the structure to 
interact with E189, results in a similar loss of binding affinity for the wild type SH3 
domain (Kd = 1.85 mM).  Based on these data, we tested the interaction further by 
introducing a positive charge at position 189 in the SH3 domain (SH3(E189K)) and a 
corresponding negative charge at position 309 in the SH2 domain (SH2(K309E)).  The 
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complex formed by these swapped mutants exhibits a tighter binding affinity (Kd = 1.08 
mM) than either of the single mutants alone.  While the affinity does not reach wild type 
levels, the fact that these mutations improve binding compared to each of the single 
mutants is consistent with there being a stabilizing electrostatic interaction between E189 
and K309 as suggested by the SH3/SH2 complex structure (Figure 5 c,d).       
Of particular interest with respect to contacts between SH2 BG loop residues 
(R332 and V330) and cleft II of the Itk SH3 domain, are the striking similarities in this 
region with another SH3/protein complex.  The Sla-1 SH3 domain binds ubiquitin and 
the structure of this protein-protein complex has been solved (pdbcode 2JT4)44.  
Superposition of the Itk and Sla1 SH3 domains shows that despite the completely 
different folds of their target protein ligands (Itk SH2 versus ubiquitin) side chain 
contacts between protein ligand (either Itk SH2 or ubiquitin) and SH3 domain binding 
site (either Itk SH3 or Sla1 SH3) are preserved (Figure 5e).    The position and orientation 
of Itk SH2 residues R332 and V330 correspond quite well to ubiquitin side chains R42 
and V70.  This region of similarity between these two SH3 mediated protein complexes 
suggests some generality in the manner by which SH3 domains recognize their non-
proline rich protein targets.   
The Itk SH3/SH2 complex structure also provides a structural interpretation for 
previously reported mutational data51.  Following T cell activation, Itk 
autophosphorylates Y180 in its own SH3 domain creating a highly negatively charged 
patch on the domain’s surface1.  From the structure reported here, we can see that the 
Y180 side chain points directly at the SH2 domain in the binary complex and in 
particular wraps around the backside of the CD loop (Figure 4b). In earlier mutational 
  
66 
analysis, we found that mutation of Y180 to glutamate, used to mimic a phosphotyrosine, 
leads to a six-fold increase in the affinity of the SH3 domain for Itk SH251.  This result 
suggests that introducing a negative charge at this position of the SH3 domain stabilizes 
the SH3/SH2 interaction.    We therefore modeled a phosphate group onto Y180 in the 
SH3 domain and find that in the Itk SH3/SH2 complex, the side chains of two basic SH2 
residues, K280 and N286, lie within reasonable donor/acceptor distance from the 
phosphate oxygens on pY180 (Figure 6).  We tested this model by further mutagenesis. 
Based on the model shown in Figure 6, mutation of either K280 or N286 in the 
SH2 domain to alanine should reduce the affinity of the Y180E SH3 domain for the SH2 
domain by removing potential hydrogen bond partners.  Since the relative population of 
cis and trans SH2 domain also affects the affinity for the Itk SH3 domain29, we first 
examined the cis/trans ratio of the mutant and wild type Itk SH2 domains.  Cis/trans ratio 
can be readily measured by comparing peak volume for cis versus trans crosspeaks in an 
HSQC spectrum of the SH2 domain28.  The population of cis and trans wild type Itk SH2 
domain is 40% and 60%, respectively.  For the K280A mutant we find no change in the 
cis/trans ratio compared to wild type but the N286A SH2 mutant exhibits a reduction in 
the cis population to 17% cis and 83% trans (data not shown).  We cannot test the N286A 
SH2 mutant for binding to SH3 (Y180E) without introducing another variable, namely 
reduction of cis population in the SH2 equilibrium ensemble and associated loss of 
affinity for SH3 by that virtue alone29.  We therefore proceeded with the more 
straightforward K280A SH2 mutant and tested binding to the Itk SH3 (Y180E) 
phosphotyrosine mimic. 
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 Binding affinity of the K280A SH2 mutant for the Itk SH3 Y180E mutant was 
measured as before34; 51 by titration of unlabeled Itk SH2 (K280A) mutant into 15N 
labeled Itk SH3 (Y180E) (Figure 6c).  Consistent with a putative interaction between 
K280 and a negatively charged residue at position 180 in the SH3 domain (Figure 6b), 
loss of the basic lysine sidechain in the Itk SH2 domain results in a loss of binding 
affinity to the phosphomimic, Itk SH3(Y180E) (Figure 6 c&d).  In fact, the affinity of 
SH3(Y180E) for the Itk SH2 domain drops ten fold upon mutation of K280 and is below 
that of the interaction between the wild type SH3 and SH2 domains (Figure 6d).  The 
titration data and the structure of the Itk SH3/SH2 complex therefore support the idea that 
autophosphorylation within the Itk SH3 domain stabilizes the self-associated form of this 
protein by enhancing the affinity of the intermolecular SH3/SH2 interaction.  These 
findings certainly need to be pursued in the context of the phosphorylated Itk SH3 
domain, but suggest that pY180 might interact with K280 alone or with both K280 and 
N286 across the SH3/SH2 interface.  
 
Discussion 
 The Itk SH3 and SH2 domains have been implicated in a number of different 
interactions 25; 27; 51; 52; 53; 54; 55; 56.  Here we report the three dimensional structure of a 
direct intermolecular interaction between these two Itk regulatory domains.  The structure 
of the SH3/SH2 complex reveals precisely how the cis prolyl imide bond at position 287 
in the SH2 domain pre-organizes the large CD loop to contact the SH3 domain (Figure 4) 
and the structure suggests specific inter-domain contacts that might stabilize the 
SH3/SH2 interaction following autophosphorylation at Y180.  As well, we have 
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discerned several other specific contacts across the interface that contribute to binding. 
Comparison with other structures, such as classical proline ligand recognition and the 
Sla1/ubiquitin complex, suggests generalities in SH3 mediated protein interactions 
(Figure 5).   
The structure of the binary SH3/SH2 complex, in conjunction with native gel 
electrophoresis, allows us to begin to visualize how larger fragments and even full length 
Itk might interact with itself intermolecularly.  The Itk SH3-SH2 dual domain fragment 
does not form simple dimers but rather is a heterogeneous mixture of oligomers.  This 
observation is consistent with the structure of the binary SH3/SH2 complex solved here.  
Grafting an SH3 domain onto the amino-terminus of the SH2 domain and likewise 
extending the carboxy-terminus of the SH3 domain to include the SH2 domain, suggests 
that a head-to-tail dimer arrangement of the SH3-SH2 dual domain fragment would not 
be sterically feasible (Fig. 7).   Instead, the model of the dual domain that emerges from 
simply extending the binary SH3/SH2 structure suggests that each Src homology domain 
interacts with a target domain from a different Itk molecule (Fig. 7).  This is consistent 
with the formation of different sized SH3-SH2 oligomers, or polymerization, as is evident 
on the native gel (Figure 1a).     
 Extending the model slightly we can place the other Itk domains (PH-TH and 
Kinase) onto this dual domain model based on the location of the amino-terminus of the 
SH3 domain and the carboxy-terminus of the SH2 domain. Albeit an incomplete picture 
of full length Itk at this point, it seems noteworthy that the PH domains of different Itk 
monomers could extend in the same direction from the N-termini of the SH3 domains in 
the context of the self-associated species.  This is important since Itk clustering has thus 
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far been observed in vivo at the membrane (rather than in the cytosol)37 and so the PH 
domain of each monomeric unit of the oligomer must be able to extend toward the 
membrane surface to engage its ligand.  As well, PH domain intermolecular self-
association has been reported30 and thus, the arrangement of the PH domain protruding 
on the same side of the SH3 domain in each Itk molecule would allow for PH/PH domain 
interactions.  
The structure of the Itk SH3/SH2 complex does not by itself provide direct insight 
into the functional significance of Itk oligomerization.  As already discussed, it does 
provide a valuable tool to begin to design targeted mutations that disrupt self-association 
in full length Itk for the purpose of understanding how these intermolecular interactions 
modulate Itk signaling.  To this end, mutations must be identified that abolish the 
SH3/SH2 intermolecular interaction while maintaining classical SH3 and SH2 ligand 
binding properties.  It is also likely that this approach will need to be extended to the 
other Itk domains (such as PH) that contribute to intermolecular self-association.  Indeed, 
native gel electrophoresis suggests that disrupting the SH3/SH2 interaction (I282A 
mutation) in the context of full length Itk does not fully abolish Itk self-association (data 
not shown) and this is consistent with reports of the Itk PH domain interacting with itself 
in an intermolecular fashion 30. 
In addition to setting the stage for targeted mutations to assess the functional 
outcome of Itk clustering in T cells, the structure reported here provides yet another 
example of the broader binding functions of the ubiquitous SH3 and SH2 domains. Add 
the Itk system to the many examples that have now been characterized demonstrating 
alternative SH3 and SH2 mediated binding 10; 11; 12; 13; 18; 19; 20; 57; 58; 59; 60; 61; 62 and we see 
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that our original notions of simple target sequences for these ubiquitous Src homology 
domains, while correct, do not represent the complete story.   
One comparison in particular stands out. A well-studied example of a direct 
regulatory interaction between an SH3 and SH2 domain is that of the SAP SH2 and Fyn 
SH3 domains mediating formation of the SLAM immune receptor complex10; 16.  Like the 
Itk SH3/SH2 complex reported here, the SAP SH2/Fyn SH3 complex involves neither a 
proline-rich sequence nor a phosphotyrosine motif.  In a manner similar to the Itk 
SH3/SH2 complex, the surface of the Fyn SH3 domain that binds SAP SH2 overlaps with 
the classical proline ligand-binding site.  The SH3 interaction interfaces are not exactly 
the same; the Itk SH2 domain overlaps to a greater extent the canonical proline-binding 
site on its partner SH3 domain than does the SAP SH2 when binding to Fyn SH3 (Fig. 
8a).  The manner by which each SH2 binding partner is engaged by the Itk and Fyn SH3 
domains is completely different (Fig. 8b,c).  As discussed in detail above, the Itk SH3 
domain contacts the CD, BG and EF loops of its cognate SH2 domain.  In contrast, the 
Fyn SH3 domain contacts the βF strand, the base of the B helix and the loop connecting 
these two regions of secondary structure within the SAP SH2 domain.  Thus, not only do 
SH3 and SH2 domains participate in a diverse set of non-classical interactions, even 
when these binding domains interact directly with each other there appears to be a 
significant degree of diversity.   
The functional role of each of these interactions must be fully understood to 
appreciate the reasons for the observed diversity.  For the Fyn/SAP complex, it has been 
clearly established that the interaction serves to activate the Fyn kinase while co-
localizing Fyn to the SAP/SLAM complex10; 16.  Thus, the mechanistic picture in this case 
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is consistent with the fact that phospholigand binding to the SAP SH2 domain does not 
compete with the interaction between SAP SH2 and Fyn SH3.  For the Itk SH3/SH2 
interaction, phospholigand binding to the Itk SH2 domain is instead mutually exclusive 
with binding of Itk SH3 to the SH2 domain27.  Hence, it seems likely that the functional 
significance of the intermolecular Itk interaction might coincide with states of the enzyme 
that do not require phospholigand association (i.e. not the activated state63).  The structure 
of the binary Itk SH3/SH2 complex reported here is a first step toward deciphering 
precisely if and how intermolecular Itk association regulates activity and localization 
during T cell signaling.   
 
Materials and Methods  
NMR Sample Preparation 
Protein expression and purification techniques were performed as described 27.  
NMR samples consisted of the free domain, 35% bound, and 77% bound for both labeled 
Itk SH2 and Itk SH3 domains (Table 1) in 50 mM NaPO4, 75 mM NaCl, 2 mM 
dithiothreitol (DTT), 5% D2O, and 0.02% (w/v) NaN3 at pH 7.4.  The extinction 
coefficient (ε) at 280 nm and isoelectric point (pI) were calculated using ExPASy (Expert 
Protein Analysis System) for the Itk SH3 (pI=4.3, ε = 19940 mM-1 cm-1) and Itk SH2 
(pI = 8.8, ε = 20400 mM-1 cm-1) domains. 
 
NMR Spectroscopy 
All NMR spectra were collected at 298K on a Bruker AVII 700 spectrometer 
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equipped with a 5mm HCN z-gradient cryoprobe operating at a 1H frequency of 700.13 
MHz.  Chemical shift assignments and NOE correlations for the free and bound Itk 
SH3/Itk SH2 structures were analyzed using CARA 64 as previously reported 40.  
Chemical shift assignments were elucidated for all structures from double and triple 
resonance experiments: CBCA(CO)NH, HNCACB, HBHA(CO)NH, HBHANH, HNCO, 
(HB)CB(CGCDCE)HE, (HB)CB(CGCD)HD, and HCCH-TOCSY, along with a 3D 15N-
edited TOCSY and 2D homonuclear TOCSY. Data were collected and independent 
assignments were made for the 35% and 77% bound samples (Table 1) since there were 
chemical shift variations among these samples due to fast exchange.  NOE correlations 
were obtained from a 2D homonuclear NOESY, 3D 13C-edited aliphatic NOESY, 3D 
13C-edited aromatic NOESY, and 3D 15N-edited NOESY spectra.  All NOESY 
experiments were acquired with a mixing time of 100 ms.  NOEs from each NOESY 
spectrum were binned into four categories: very weak, weak, medium, and strong with a 
total percent NOE restraint ratio of 20:30:30:20. The corresponding structural restraints 
have bounds of 1.8-6.0Å, 1.8-5.0Å, 1.8-3.3Å (3.5Å for amide groups), and 1.8-2.5Å 
(2.7Å for amide groups), respectively.  To account for the higher intensity of NOEs 
involving methyl groups 0.5Å was added to each of these restraints with an upper bound 
no greater than the very weak upper bound limit of 6.0Å.  IPAP 1H-15N correlation 
experiments and 3D HNCA E-COSY 15N-13C experiments were performed to measure 
residual dipolar coupling constants.  Weak anisotropic alignment was achieved through 
the addition of 8 mg mL-1 of Pf1 phage (ASLA BIOTECH Ltd) 65; 66.  The quality of all 
structures was evaluated using PROCHECK_NMR 67 and WHATCHECK 68. 
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Unbound Structure Calculations 
The unbound Itk SH3 structure used for comparison to the bound complex was 
recently reported 40.  The previously solved structure of the unbound cis imide bond 
containing SH2 conformer 28 was refined with the addition of RDC restraints from IPAP 
1H-15N correlation experiments.  RDC data from 3D HNCA E-COSY 15N-13C 
experiments could not be measured for the SH2 domain in both unbound and bound 
samples due to line broadening from exchange.  Previously reported NOE restraints were 
verified and NOE restraints were generated in CARA from the newly acquired data.  
Hydrogen bond and torsion angle restraints from the previous unbound cis SH2 domain 
structure calculation were used unmodified.  The refined unbound cis conformer of the 
Itk SH2 domain was calculated using simulated annealing in XPLOR-NIH with NOE, 
hydrogen bond, RDC, and torsion angle restraints.  Ramachandran plot statistics in the 
core, allowed, generously allowed, and disallowed regions for residues in the average 
structure are 77.9%, 12.6%, 7.4%, and 2.1% respectively. The backbone (N, Ca, C’) and 
heavy atom RMSD is 0.89Å and 1.57Å respectively.  
 
Individual Bound Structure Calculation 
The individual bound structures of Itk SH2 and Itk SH3 were calculated 
independently using NOE, RDC, and torsion angle restraints.  Initial estimates of 
alignment tensor terms Da (axial symmetry) and R (Rhombicity) for the bound structures 
were calculated via SVD (singular value decomposition) using the average minimized 
unbound structures of Itk SH2 and Itk SH3.  The Da and R values of -11.00 and 0.3 
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respectively used in the bound structure calculations of SH2 and SH3 were calculated by 
a grid search of tensor terms around the initial estimate determined by SVD.  Dihedral 
angle (φ, ψ) restraints were obtained from a large structural database using PREDITOR69.   
Chemical shifts from the more completely assigned 35% bound data set were used as 
input to PREDITOR.  Bounds of ± 60° were chosen to allow for variability in calculated 
torsion angle restraints that may arise in chemical shift differences of the fully bound 
assignments and the 35% bound assignments.  
 
Itk SH3/SH2 Complex Structure Calculation 
The binary complex was determined from the bound domain structures in 
XPLOR-NIH using conjoined rigid body/torsion angle dynamics based on 59 
intermolecular NOE distance constraints (depicted on the complex structure in Figure 2S; 
Supplementary Material) and 58 DNH RDC constraints.  Intermolecular NOEs were 
obtained by comparing 3D 13C-edited aliphatic NOESY, 3D 13C-edited aromatic NOESY, 
and 3D 15N-edited NOESY spectra of bound and unbound samples.   The intermolecular 
NOEs were manually assigned and binned. Distant restraints associated with the strong, 
medium and weak NOES were generated with upper bounds of 3.5, 4.7 and 5.5 Å, 
respectively.  In this calculation, the bound structures are held rigid except for residues 
found at the interface. Interfacial residues were determined as those exhibiting all three of 
the following criteria:  (a) significant chemical shift perturbation upon binding, (b) 
solvent exposure and (c) forming a contiguous surface 38.  Criteria (b) and (c) were 
assessed by visual inspection of a space-filling representations of the domain structures. 
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For Itk SH3 residues 179-185, 188-189, 205-208, 220, 222-225, and 227-228 and for Itk 
SH2 residues 258-260, 278-292, 326-332 comprised the flexible interfacial residues.  A 
lowest energy structure from the calculation was chosen as an initial structure for further 
refinement using simulated annealing.  Ramachandran plot statistics in the core, allowed, 
generously allowed, and disallowed regions for residues in the average structure are 
70.2%, 25.2%, 2.6%, and 2.0%, respectively. The average backbone RMSD (N, Ca, C’) 
is 0.68 Å and average heavy atom RMSD is 1.28 Å (Table 1).  The average buried 
interfacial surface area calculated from the twenty lowest energy structures of the 
SH3/SH2 binary complex was determined using NACCESS 70.  The portion of the 
interaction surface that corresponds to the transient CD loop of the SH2 domain was 
calculated from the individual contributions of residues 279, 280, 281, 282, and 283 to 
the interaction surface. 
 
Native Gel Analysis 
Native gels were run as described previously71.  Briefly, purified Itk wild-type or 
mutant SH3SH2 domain was mixed in a 1:1 ratio with native gel loading dye. The 
proteins were loaded on a 10 % discontinuous native gel and run at 180V with Tris Cl pH 
8.8 as the running buffer. BSA was used as the standard. The gels were then stained with 
Coomassie stain. 
 
Structural Comparison and Alignment 
All alignments of unbound structures with the binary complex were performed in 
PyMol 72 between backbone atoms (C’, Cα, N) and residues 235-335 for the Itk SH2 
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domain and residues 173-229 for the Itk SH3, respectively.  To ensure all backbone atoms 
are included, the align command was performed with zero cycles of refinement.  Similar 
alignments were made between the Itk SH3 domain of the Itk SH3/SH2 complex with the 
Sla-1 SH3/ubiquitin complex and the SAP/Fyn complex. 
To model pY180 in the Itk SH3 domain, the phosphotyrosine in the 
phosphopeptide ligand of Itk SH2/pY ligand complex structure was aligned with Y180 in 
the Itk SH3/SH2 complex structure.  This aligned phosphotyrosine residue was used to 
represent the pY180 phosphorylated form of the SH3/SH2 complex structure. 
 
NMR Titrations 
Point mutations for the titrations were generated using the Quick change Site-
Directed Mutagenesis kit (Stratagene).  NMR titrations were carried out as described 29; 
33; 34 where unlabeled protein was incrementally added to a 400 µM 15N-labeled protein 
sample.  After each addition, the changes in chemical shift of resonances in a 1H-15N 
HSQC were recorded. Chemical shift perturbations were determined significant if the 
change in the position of a crosspeak was greater than the average of all crosspeak 
change plus one standard deviation.  The 1H and 15N chemical shift difference were 
combined into an average chemical shift using the equation: 
 
Dissociation constants (Kd) were determined using an in-house program written in 
Matlab (version 5.3.1, The Mathworks, Inc) that fits the following equation:   
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where Δδ is the chemical shift difference, [P]0 is initial protein concentration, [L]0 is 
initial ligand concentration and Ka (= 1/Kd) is the association constant.  Parameters Ka 
and δmax are both fitted in the analysis.  
 
Percent Cis/Trans Calculation 
Cis/trans isomerization of the Asn 286-Pro 287 imide bond is in the slow 
exchange NMR regime resulting in two distinct cross-peak resonances for approximately 
a third of the residues in a 1H/15N HSQC of the Itk SH2 domain.  The ratio of cis/trans 
conformers for wild type Itk SH2, SH2(K309E), and SH2(K280A) was calculated from 
well resolved cross-peaks of the following residues: 256, 258, 260, 278, and 290.  The 
fraction of SH2 domain that adopts the cis conformer expressed as percent is calculated 
by taking the intensity of a crosspeak that corresponds to the cis conformer, dividing by 
the sum of the crosspeak intensities of the cis and trans conformers, and multiplying by 
100.  The percent of SH2 domain containing the trans imide bond conformation is 
calculated in the same way. 
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Accession Codes 
The RCSB PDB accession codes for 20 lowest energy structure ensemble and average 
minimized structure are 2K7A and 2K79, respectively.  The BMRB accession number is 
15912. 
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Figure Captions: 
Figure 1:  (a) Native gel electrophoresis was carried out to compare the Itk SH3-SH2 
dual domain fragment (lane 2) and the same Itk SH3-SH2 fragment with Ile 282 mutated 
to alanine (Itk SH3-SH2(I282A), lane 4).  Lanes 1 and 3 are Bovine Serum Albumin 
(BSA) standard.  (b)  Intermolecular NOEs are evident in 3D 13C-edited NOESY spectra.  
Two-dimensional slices corresponding to side chain protons of W208 are shown for free 
SH3 domain (unbound), 35% bound SH3 domain, and 77% bound SH3 domain.  
Intermolecular NOEs between protons on the SH3 and SH2 domains are boxed and 
labeled in the spectra of 35% and 77% bound SH3 domain.  The corresponding regions of 
the spectrum of free SH3 domain (unbound) are also boxed showing the absence of these 
intermolecular NOEs for the isolated SH3 domain.  
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Figure 2: (a) Superposition of Cα backbone traces of the 20 lowest energy structures 
calculated for the binary complex between the Itk SH3 and Itk SH2 domains.  The SH3 
domain is shown in teal and the SH2 domain is gray. The amino (N)- and carboxy (C)-
termini of both the SH3 and SH2 domains are labeled.  (b) Stereoview of the average 
SH3/SH2 binary complex structure.  
 
Figure 3:  (a) Ribbon representation of the Itk SH3/SH2 complex structure showing the 
canonical ligand binding sites on each domain.  (left) The pY and pY+3 binding pockets 
on the Itk SH2 domain are circled and labeled.  The sidechains that comprise the pY 
pocket are shown in red.  The loop regions of the Itk SH2 domain that contact the Itk 
SH3 domain in the complex are labeled CD, BG and EF using standard SH2 domain 
nomenclature. (right) The view in (a) has been rotated 180 degrees and the conserved 
SH3 biding pocket is circled and labeled.  The aromatic residues that make up the 
proline-binding site on the SH3 domain are shown in red.  In both views the amino (N)- 
and carboxy (C) termini of each domain are labeled.  (b) Surface rendering of the Itk 
SH3/SH2 complex shows the fit between SH3 and SH2 domains in the complex.  The 
conformation of the cis CD loop in the SH2 domain (labeled in the mesh representation 
on the right) contributes to the curved surface (or hand-like shape) presented to the SH3 
domain.  The color scheme for each domain is the same as in Figure 2. 
 
Figure 4: Cis/trans isomerization of the Itk SH2 domain affects contacts between SH2 
and SH3 domains.  (a) Ribbon representation of the complex between the Itk SH3 
domain (teal) and Itk cis SH2 domain (darker gray).  The structure of the trans imide 
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bond containing SH2 conformer (light gray) is superimposed with the cis SH2 domain of 
the complex.  The EF, BG and CD loops of the SH2 domain are labeled as is the cis Pro 
287.  Three residues of the CD loop (A281, I282 and I283) are shown in red (and labeled 
in (b)).  For the trans CD loop, the same three side chains are shown in gray and labeled.  
(b) Expanded view of boxed region in (a) showing interface contacts between the CD 
loop of the cis SH2 domain and sidechains on the SH3 domain surface.  SH3 domain side 
chains are teal and SH2 domain sidechains are red. 
 
Figure 5: Comparing the Itk SH2 ligand with the classical proline-rich ligand for SH3 
domains.  (a) Schematic of classical SH3/ligand interaction. Proline-rich ligands (such as 
the KPLPPTP sequence shown here) make contacts to three distinct binding clefts on the 
SH3 domain, labeled I, II and III.  The lysine and leucine ligand residues are circled since 
they appear to be most closely mimicked by residues of the Itk SH2 domain.  (b) 
Structure of the Itk SH3/SH2 complex highlighting interface residues in the EF, BG and 
CD loops of the SH2 domain (side chains labeled and shown in red).  Also shown in this 
structure are the sidechains of two highly conserved SH3 residues, W208 and E189, 
which contact both proline-rich ligands as well as the bound SH2 domain in this 
structure. (c)  Structural comparison of the SH2 ligand and a proline-rich ligand bound to 
the Itk SH3 domain.  The view in (b) is rotated to view straight into the SH3 binding 
surface and then the SH2 domain is removed for clarity leaving only five SH2 residues at 
the interface (K309, R332, V330, T279 and A281 in red).  In addition, the structure of the 
Itk SH3 domain bound to a canonical ligand (pdbcode 1AWJ) is superimposed with the 
Itk SH3 domain in the SH3/SH2 complex.  For clarity the Itk SH3 domain in the 
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proline/SH3 structure is not shown and the proline-rich ligand is depicted in blue with 
side chains labeled: Lys, Leu, Pro, Thr, Pro.  The conserved E189 is outlined with a 
dashed line and highlighted in blue on the teal surface of the Itk SH3 domain. (d) 
Increasing concentration of unlabeled Itk SH2 domain was titrated into 15N labeled Itk 
SH3 domain.  1H-15N HSQC spectra were obtained after addition of each aliquot of SH2 
ligand.  Binding curves were generated by plotting the normalized concentration 
dependence of amide chemical shifts for several different residues.  Dissociation 
constants (Kd) were derived from binding curves shown as described in Methods.  The 
pairs of SH3 and SH2 domains for each titration are: ∆ wild type SH3/wild type SH2; ⋅ 
SH3 (E189Q)/wild type SH2; ◊ wild type SH3/SH2(K309E);  
SH3(E189K)/SH2(K309E). (e) Comparison of the Itk SH3/SH2 interface with the Sla-1 
SH3/ubiquitin interface.  Overlay of the Itk SH3(teal)/SH2 (dark gray) complex and the 
complex of Sla-1 SH3 (white)/ubiquitin complex.   After alignment of only the SH3 
portions of each complex, residues R332 and V330 of Itk SH2 (red) correspond very well 
with residues R42 and V70, respectively of ubiquitin (green) despite the very different 
tertiary structures of the Itk SH2 domain and ubiquitin.  The conserved tryptophan in 
each SH3 domain are shown (Itk SH3 is teal, Sla1 SH3 is gray) and labeled.   
 
Figure 6:  Autophosphorylation of Y180 in the structural context of the Itk SH3/SH2 
complex.  (a) Structure of the Itk SH3/SH2 complex labeled as before.  Y180 in the SH3 
domain is shown with a phosphate group modeled as substituting at the hydroxyl group.  
(b) Enlarged view of boxed area in (a).  Distances in the model between the phosphate 
oxygens and the side chain nitrogens of K280 and N286 are shown.  (c & d)  NMR 
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titrations to determine dissociation constants as described in Figure 5d. The pairs of SH3 
and SH2 domains for each titration are: ∆ wild type SH3/wild type SH2;   
SH3(Y180E)/wild type SH2;  SH3(Y180E)/SH2(K280A). 
 
Figure 7:  Model of Itk oligomerization.  Two copies of the binary SH3/SH2 complex 
structure are shown using the same color scheme as in other figures. The amino-terminus 
of each SH2 domain is then connected (using a dotted line) to the carboxy-terminus of 
the Itk SH3 domain (labeled SH3-SH2 linker), the carboxy-terminus of each SH2 domain 
is extended toward the Kinase domain (labeled SH2-Kinase linker) and the amino-
terminus of each SH3 domain is extended toward the PH-TH domains. Thus, one 
monomeric unit of Itk consists of PH-TH-SH3-SH2-Kinase.  Three such Itk units are 
shown and the interaction interface between SH3 and SH2 domain is labeled.  The SH2 
and SH3 binding sites of the SH3 and SH2 domains, respectively, at each end of the 
oligomer are circled to suggest further interactions are possible. 
 
Figure 8: Comparison of Itk SH3/SH2 structure and Fyn SH3/SAP SH2 structure 
(pdbcode 1M27).  (a) For both complex structures, the Itk SH3 domain and the Fyn SH3 
domain (both shown in teal) are superimposed.  The conserved tryptophan in the SH3 
domain binding cleft is shown for both Fyn and Itk and labeled W.  With superposition of 
the SH3 domains, it is clear that the bound SH2 domains do not contact precisely the 
same region of their cognate SH3 domain but both bind in a manner that would overlap 
with classical proline ligand binding.  The Itk SH2 domain is gray and the SAP SH2 
domain is gold.  The SLAM derived phosphopeptide bound to the SAP SH2 domain is 
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depicted in red. (b & c)  The Itk SH3/SH2 complex (b) and the Fyn SH3/SAP SH2 
complex (c) are shown separately with the SH2 domains in exactly the same orientation.  
The respective SH3 domains (shown in teal) interact with distinct regions of the different 
SH2 domains (SH2 secondary structural regions and loops involved in each complex are 
labeled).  The SLAM peptide bound to the SAP SH2 domain is shown in red.  It is clear 
in this comparison that the bound Itk SH3 domain partially occludes the classical ligand-
binding site of the Itk SH2 domain. 
 
Supplementary Material 
Figure Captions: 
Figure 1S: 
Similarities between free and bound Src hmolgy domains are shown in the superposition 
of the structures of the isolated Itk SH3 and cis SH2 domains (shown in light grey) with 
the corresponding domains in the Itk SH3/SH2 complex.  
 
Figure 2S: 
Superposition of the Itk SH3/SH2 complex depicting the 58 intermolecular NOE 
restraints used in the NMR structure calculation. The SH3 and SH2 domains are colored 
in cyan and gray, respectively.  The intermolecular NOE restraints are primarily between 
the SH3 binding pocket and the three loops of the Itk SH2 domain (CD, BG and EF).  
The red and cyan lines are NOEs involving SH2 CD loop residues, magenta involves 
residues of the BG loop, orange indicates NOEs to the end of the βD strand, and green 
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are NOEs to the EF loop.  Side chains giving rise to NOEs are depicted but hydrogens are 
not included for clarity. 
 
 
Table 1:  Compositions of NMR Samples 
ID NMR Sample Percent bound
1 1.5 mM 
13
C, 
15
N labeled Itk SH3 0%
2 1.5 mM 
13
C, 
15
N labeled Itk SH2 0%
3 3.4 mM 
13
C, 
15
N labeled Itk SH3 with 1.5 mM unlabeled Itk SH2 35%
4 3.4 mM 
13
C, 
15
N labeled Itk SH2 with 1.5 mM unlabeled Itk SH3 35%
5 1.5 mM 
13
C, 
15
N labeled Itk SH3 with 3.4 mM unlabeled Itk SH2 77%
6 1.5 mM 
13
C, 
15
N labeled Itk SH2 with 3.4 mM unlabeled Itk SH3 77%
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Table 2: Structural Statistics  
 
Experimental Restraints   SH2bound SH3bound SH3/SH2 
NOEs   2439 1351 3849+ 
CDIH   191 110 301 
RDC NH 33 25 58 
  CAHA 0 18 18 
Total   2663 1504 4226 
          
Restraint Statistics         
RMSD from standard 
geometry        
Bonds(Å)  0.004(0.001) 0.004(0.001) 0.005(0.001) 
Angles(deg)  0.479(0.050) 0.577(0.028) 0.580(0.040) 
Improper(deg)  0.405(0.042) 0.466(0.041) 0.501(0.026) 
RMSD from experimental 
restraints        
Distance(Å) 0.046(0.003) 0.051(0.003) 0.058(0.003) 
CDIH(deg) 0.383(0.125) 0.547(0.271) .691(0.211) 
          
Ramachandran Plot++         
(percent of residues)         
Core   73.7 76.8 70.2 
Allowed   20 21.4 25.2 
Generously Allowed   3.2 1.8 2.6 
Disallowed   3.2 0 2.0 
Average RMSD (Å)         
  CA,C,N 0.60 0.40 0.68 
  
not 
hydrogen 1.25 1.03 1.28 
+ includes 59 intermolecular NOEs 
++ Determined from the average structure 
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CHAPTER 5.  MULTIPLE INTERMOLECULAR INTERACTIONS 
LEAD TO OLIGOMERIZATION IN ITK 
 
A collection of unpublished data 
 
Abstract: 
Protein interaction domains in multidomain proteins are a well known targeting 
mechanism required for cellular signaling.  It is now emerging that these same domains 
play an important regulatory role by changing the oligomeric state and the quaternary 
conformation of multidomain proteins.  Interleukin-2 tyrosine kinase (Itk) is a non-
receptor tyrosine kinase of the Tec family important in T-cell immune response.  Itk is 
comprised of four regulatory domains: PH (Pleckstrin homology), TH (Tec homology), 
SH3 (Src Homology 3), SH2 (Src Homology 2), and the catalytic kinase domain.  The 
Tec family kinases members exhibit intermolecular self-association that is believed to be 
important in their regulation.  Based on the SH3/SH2 complex structure (Chapter 4), we 
explore a possible configuration of the oligomeric state of Itk using native gel analysis 
and structural modeling in Xplor-NIH. 
 
Introduction: 
Homo-oligomerization of non-receptor tyrosine kinases are known to increase the 
affinity for down-stream signaling targets and binding partners, enhance protein stability, 
and provide an additional level of regulation 1; 2; 3; 4; 5; 6; 7; 8.  The family of Tec non-
receptor tyrosine kinases also shares an oligomerization property important in proper cell 
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signaling and more recently is believed to be important in kinase regulation (unpublished 
data of L. Min and W. Wu). 
 Tec family kinase members have three main steps for activation: localization to 
the membrane, association with an adaptor protein complex, and phosphorylation by a 
Src family kinase member 9.  Once activated, the Tec family kinase member, Itk, is 
involved in many down-stream signaling events.  The primary downstream signaling 
target for Itk phosphorylation is phospholipase C-γ1 (PLCγ-1)10.  Activated PLCγ-1 
hydrolyzes phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) to diacylglycerol and 
inositol 1,4,5-triphosphate.  These secondary messengers are responsible for intracellular 
Ca2+ mobilization and the activation of the Ras-Raf-MEK-ERK pathway 11 leading to 
interleukin-2 production and T-cell proliferation 12; 13. 
Although Itk activation and many of its down-stream signaling effects are well 
characterized, the mechanism behind Tec family kinase regulation is not clear.  Kinases 
from the Src kinase family, however, are known to form a kinase inhibitory conformation 
supported by intramolecular interactions between SH2 and SH3 domains and a 
phosphotyrosine containing C-terminal tail and the linker between the SH2 and kinase 
domains respectively 14.  Tec family kinases lack the C-terminal tail and therefore are 
regulated in a different manner than Src family kinases and although the exact regulatory 
mechanism is unknown, intermolecular self-association is common within Tec family 
kinases and may have a functionally significant role1; 2; 3; 4; 5; 6.  Tec kinase, the prototypic 
member of the Tec family kinases, contains an intermolecular self-association between its 
SH3 domain and its two adjacent proline rich regions 6.  Dimerization between the SH3 
and proline rich region is also found in two other Tec family members, Txk and Btk 4; 5.  
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Additionally, it was found that the Btk structure of the PH domain crystallizes as a dimer 
with two molecules present in the asymmetric unit 3.  Itk self associates intermolecularly 
through two known binding mechanisms between the SH2 and SH3 domains and 
between the PH domain with itself 15 16, readily co-immunoprecipitates with itself15; 17, 
and forms intermolecular clusters at the membrane in response to T-cell receptor 
stimulation 18. 
To explore the functional role of intermolecular self-association in Tec kinases, 
the interaction between the Itk SH3 and SH2 domains was further investigated 
(unpublished data of L. Min and W. Wu) by the introduction of mutations that eliminated 
the SH3/SH2 interaction.  The point mutation I282A in the SH2 domain disrupts the 
preorganization of the CD loop resulting in the disruption of the SH3/SH2 interaction 16.  
However, this single point mutation reduces binding affinity of the SH2 domain to the 
canonical phosphotyrosine peptide 16 thereby altering more than one binding interaction 
for this domain.  Ideally, it would be beneficial to identify mutations that disrupt the 
SH3/SH2 interaction but maintain canonical ligand binding properties.  These mutations 
could then be used to determine the role of the SH3/SH2 interaction in larger constructs.  
To this end, it was noted that the SH3/SH2 interaction is specific to Itk in the Tec kinase 
family, for example the Btk SH3 domain does not interact with the Itk SH2 domain 19.  
Therefore, the SH3 domain of the Tec family kinase, Btk, was introduced into the full-
length Itk sequence creating a chimeric ItkBtkSH3 mutant that reduces SH3/SH2 mediated 
intermolecular self-association while maintaining canonical ligand binding properties 
(unpublished data of L. Min and W. Wu).   
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 Previous in vitro kinase assays using peptide-B as a substrate to measure Km and 
Kcat activity levels for Itk and ItkBtkSH3 mutants indicate that kinase activity for wild type 
Itk decreases with increasing kinase concentration whereas the kinase activity of the 
ItkBtkSH3 mutant increases linearly with increasing kinase concentrations.  Previous In vivo 
studies of Itk and ItkBtkSH3 transfected primary CD4 T-cells monitored by immunoblot for 
phospho-ERK (Ras-Raf-MEK-ERK pathway) support the in vitro work indicating a 
higher ERK activation and therefore a higher Itk activation following T-cell receptor 
stimulation for the ItkBtkSH3 mutant than wild type Itk.  These two results (unpublished 
data of L. Min and W. Wu) suggest an inhibitory role for the Itk SH3/SH2 interaction and 
Itk self-association. 
Given our still limited understanding of Itk self-association, we performed native 
gel analysis to determine the role of the SH3/SH2 interaction in the oligomerization state 
of Itk.  Native gel experiments were performed on full length Itk that indicate 
oligomerization (unpublished data of Raji Joseph).  However, a significant portion of the 
protein did not migrate beyond the well indicating possible precipitation of high order 
oligomers.  To investigate more specifically the role of the SH3/SH2 interaction the PH 
and TH domains were removed from the Itk sequence to eliminate the known PH-PH 
domain interaction 15 and simplify data analysis.  We show that the Itk SH3-SH2 
fragment oligomerizes and that the Itk SH3-SH2-kinase fragment might contain another 
interaction that supports oligomerization independent of the known SH3/SH2 interaction.   
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Results 
Native gel indicates Itk oligomerization 
 In an effort to understand the regions in Itk involved in self-association, several 
constructs of varying size were generated (Figure 1).  We started the characterization of 
Itk oligomerization with the SH3-SH2 fragment of Itk.  Native gel analysis was used to 
characterize the self-association of Itk.  Since the protein is not denatured, any oligomers 
of the protein will appear on the gel as multiple bands within the sensitivity of staining by 
Coomasie brilliant blue. 20  For the SH3-SH2 construct, the gel shows a ladder of these 
bands that indicates self-association of the SH3-SH2 fragment to high order oligomers 
distinguishable up to seven bands representing at least a 7-mer and appears to continue 
beyond this oligomeric state (Figure 2: lane 2).  Although the exact oligomeric state of 
these bands is unknown at this time, each band on the gel represents a state of 
oligomerization that is at least one order higher than the previous band.  Therefore, we 
will refer to the bands as X+-mers where X is the number of bands visible and the plus 
indicates that Itk may be oligomerizing not as a monomer but a higher order oligomer to 
achieve the same banding pattern. 
To verify that the self-association of the SH3-SH2 fragment was a result of the 
known interaction surfaces between the Itk SH3 and Itk SH2 domains, the SH3-SH2(Btk 
SH3) and SH3-SH2(I282A) mutant constructs were examined by native gel analysis.  As 
shown in Figure 2 (lanes 3,4), the mutants that are known to significantly diminish the 
binary SH3/SH2 interaction also showed a significant reduction in oligomerization in the 
context of the dual domain construct.  
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With this result, we continued our exploration of Itk self-association with the 
larger SH3-SH2-kinase domain (32KD) fragment.  This fragment also contains oligomers 
up to and beyond the 7+mer  (Figure 2: lane 6).  We expected the 32KD(Btk SH3) mutant 
to exhibit a similar reduction of oligomerization as seen in the SH3-SH2(Btk SH3) 
fragment that lacks the linker-kinase region.  We found, however, that the 32KD (Btk 
SH3) mutant oligomerized to the a similar extent as wild type 32KD (Figure 2: lane 7) 
suggesting that another site of self-association may be present in 32KD fragment that 
supports oligomerization.   
To test this hypothesis, N-terminal deletion constructs of the 32KD fragment were 
ran on a native gel.  As shown in Figure 2 (lanes 9,10,11), the SH2-kinase domain (2KD) 
fragment in the absence of the SH3 domain and the linker-kinase domain (LKD) 
fragment in the absence of the SH3 and SH2 domains both show oligomerization up to a 
7+-mer and 3+-mer, respectively, whereas the kinase domain alone shows little to no 
oligomerization.  These data support the hypothesis of another site of self-association in 
the SH2-kinase fragment of itk. 
 
Potential model for the SH3-SH2 construct oligomerization was built 
 Of the three potential oligomerizing interactions (PH/PH, SH3/SH2, 
2LKD/2LKD), only the structure of the SH3/SH2 interaction has been solved for Itk 16 
(pdbcode 2K7A).  From this structure, we see that the N and C-termini of each domain 
are facing in opposite directions (Figure 3a).  We also know that the linker length 
between the SH3 and SH2 domains is relatively short; seven residues.  Given the limited 
structural information for an Itk oligomer, we decided to model the basic unit of 
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oligomerization, the dimer, using the Itk SH3-SH2 fragment and the known SH3/SH2 
complex structure (Figure 3b).  The SH2 and SH3 domains of the SH3/SH2 complex 
(pdbcode 2K7A) were used to create a SH3-SH2 fragment by linking the C-terminus of 
the SH3 domain with the N-terminus of the SH2 domain (Figure 3b).  Two SH3-SH2 
fragments were then aligned with the SH3/SH2 complex to create a starting structure for 
minimization in Xplor-NIH 21 (Figure 3c).   
 Simulated annealing was performed keeping the SH3/SH2 interaction fixed and 
allowing the two remaining unbound domains in the SH3-SH2 fragment dimer to sample 
the conformational space allowed from the flexible seven residue linker (figure 4).  From 
this model, we can see how the SH3/SH2 interaction contributes to higher order 
oligomerization.  100 structures were generated during the simulated annealing run and 
the results suggest that the SH3 and SH2 domain structures linked to the SH3/SH2 
complex remain on the same side of the complex in which they were linked.  This is 
evident in the ensemble of the 20 lowest energy structures.  We find a conformational 
space (represented by trapezoids in Figure 4a) for the unbound SH3 and SH2 domains in 
the putative dimer that excludes the possibility of their binding to each other.  This 
implies that the SH3/SH2 interaction will have two domains free to bind another SH2 or 
SH3 respectively to achieve higher order oligomers ad infinitum (Figure 4b).  Figure 4c 
contains a model of the Itk SH3-SH2 dimer chosen from the ensemble. 
Ideally, analytical ultracentrifugation (AUC) and dynamic light scattering (DLS) 
can be used to further characterize the Itk oligomer.  To date, we have had difficulty 
using these techniques for Itk and its fragments.  Based on the native gel analysis 
described above, Itk populates several oligomeric states, however, the high order 
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oligomers appear to be at much lower protein concentrations than the putative monomer.  
Indeed, both DLS and AUC detect the major monomeric species in solution (data not 
shown).   DLS requires that the oligomers are at least five-fold different in their 
hydrodynamic radius (for instance a monomer and a 5-mer) otherwise a weighted average 
molecular weight is returned that is based on the fraction of protein in each oligomeric 
state.   
Using DLS, we find an apparent molecular weight near the monomeric molecular 
weight, which is consistent with the monomer being the most concentrated species in 
solution.  Additionally, sample preparations for DLS require high-speed centrifugation 
and in some cases filtration that could remove or bias the heterogeneous sample to lower 
order oligomeric species.  In fact, we note a drop in Abs280 after spinning Itk samples at 
14,000 rpm in a tabletop centrifuge for 10 minutes suggesting loss of protein possibly 
precipitation of high order oligomers (unpublished data).  
AUC data analysis becomes difficult beyond three oligomeric species in solution. 
In fact, Ultrascan currently limits users to models with three or fewer oligomeric species 
22; 23.   Native gel experiments indicate there are greater than three oligomeric species in 
solution for Itk.  Additionally, AUC requires that the Abs280 be between ~0.4 and ~1.2 
limiting the maximum concentration possible for Itk samples.  This affects the oligomeric 
state of Itk depending on the binding affinity of the fragment under study.  We are 
currently pursuing avenues to overcome these challenges and will revisit these techniques 
in the future.   
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Discussion 
Native gel analysis indicates that Itk exhibits higher order oligomerization in 
solution.  Oligomerization is evident even in the absence of the previously identified 
intermolecular PH/PH and SH3/SH2 interactions of Itk indicating the presence of an 
additional intermolecular interface located in the 2KD fragment of Itk.  Modeling efforts 
to understand the oligomerization of the SH3-SH2 fragment indicate a mechanism for 
oligomerization that accounts for the presence of a 7+-mer on the native gel.   
Mutations were previously identified that eliminate the SH3/SH2 interaction.  
Similarly, mutations that increase the binding affinity of the SH3/SH2 interaction could 
be identified from the SH3/SH2 complex structure.  The SH3Y180E mutation has 
previously been reported to increases binding affinity between the Itk SH3 and SH2 
domains 24.  The mutation SH3H207F has also been shown to increase binding affinity 
(data not shown).  We created the double mutant SH3Y180E/H207F to determine if the 
single mutations would behave cooperatively.  It turns out that the double mutant does 
not behave cooperatively.  We are currently in the process of identifying other mutations 
that may behave cooperatively in an effort to increase the binding affinity between the Itk 
SH3 and SH2 domains.   
The experiments used before to characterize kinase activity for the full-length Itk 
(BtkSH3) mutant that disrupts the SH3/SH2 interaction could be repeated for the high-
affinity mutant that increases the SH3/SH2 interaction.  In vitro kinase assays using 
peptide-B as a substrate to measure Km and Kcat activity levels are expected to indicate a 
kinase activity for the high-affinity Itk mutant that decreases more rapidly with increasing 
kinase concentrations than the wild type Itk.  Similarly, in vivo studies of Itk and the Itk 
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mutant transfected into primary CD4 T-cells monitored by immunoblot for phospho-ERK 
are expected to indicate a lower ERK phosphorylation following T-cell receptor 
stimulation for the high-affinity Itk mutant than the wild type Itk.  These experiments 
together would further support the functionally significant role of self-association in Itk 
kinase inhibition. 
 Creative use of the known mutations that increase 24 (SH3Y180E and SH3H207F) 
or decrease 16; 24 (SH2I282A and SH2K309E) SH3/SH2 binding affinity could also be 
used to create an Itk SH3-SH2 dimer without higher order oligomerization (Figure 4c).  
To accomplish this Itk dimer, two SH3-SH2 constructs are required.  The first construct 
could contain mutations that increase SH3/SH2 binding affinity in its SH2 domain but 
eliminate this binding affinity in its SH3 domain.  The second construct would 
complement the first SH3-SH2 construct with mutations in the SH3 domain that increase 
SH3/SH2 binding affinity and mutations in the SH2 domain that eliminate this binding 
affinity.  Each SH3-SH2 construct should therefore be monomeric.  The combination of 
these two SH3-SH2 constructs in solution could then lead to a non-oligomerizing Itk 
SH3-SH2 dimer.   
 This construct could be characterized with NMR and X-ray crystallography to 
obtain a structure of the Itk SH3-SH2 fragment bringing us one step closer to 
understanding the SH3/SH2 interaction in the context of full length Itk.  Once similar 
mutations can be identified to break up the PH/PH and 2LK/2LK interactions, full length 
Itk constructs that self-association through only one of these interactions would allow us 
to explore each interaction in turn to obtain a better understanding of how each 
interaction contributes to Itk self-association, oligomerization, and regulation. 
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 A single structure cannot adequately describe the diverse range of interactions in 
which multi-domain proteins participate.  We describe here the oligomerization of Itk 
through the intermolecular SH3/SH2 interaction.  Previous work in our lab indicates that 
the same interaction surface on the SH2 domain is involved in an intramolecular docking 
interaction with the kinase domain during Itk autophosphorylation of Y180 in the SH3 
domain 25 (represented as a magenta surface in Figure 5).  The significant overlap in the 
binding surfaces of the SH2 domain indicate that these two binding events are mutually 
exclusive suggesting that Itk exists in multiple conformational states.  The structure of the 
SH2/kinase interaction is currently unknown, however, structural modeling in Xplor-NIH 
may provide some structural insight into Itk autophosphorylation.  The quaternary 
structure of a protein provides yet another level of complexity in understanding the 
regulation of biochemical signaling pathways.  Further structural studies are required to 
understand the structural and functional role of intermolecular self-association in Itk and 
the many potential intramolecular Itk conformation that likely exist. 
 
Materials and Methods: 
Constructs 
 Baculoviral constructs for the full-length (residues 1-618), SH3-SH2-kinase 
(residues 171-618), SH2-kinase (residues 230-618), and linker-kinase (residues 339-618) 
were generated as previously described 23; 24; 26.  The chimera Itk SH3Btk-SH2-kinase 
construct was generated by replacing the Itk SH3 domain (residues 171-232) with the 
human Btk sequence (residues 214-275) using PCR.  Point mutations in the bacterial 
constructs of Itk SH2 27 and Itk SH3 28 for the titration analysis were generated using the 
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Quick Change site-directed mutagenesis kit (Stratagene).  All constructs were verified by 
sequencing at the Iowa State University DNA synthesis and sequencing facility. 
 
Protein expression and purification 
 Bacterial protein expression and purification techniques were performed as 
described 16; 19; 28.  Sf9 protein expression and purification techniques were also 
performed as described 24; 29 with minor modifications.  Briefly, the cell pellets were 
resuspended in lysis buffer (50 mM Tris HCL (pH 8.0), 500 mM NaCl, 2 mM EDTA, 
1mM PMSF) and lysed by dounce homogenization.  The cell lysate was spun at 16,000 
rpm (30,000g) for 1 hr at  4 °C.  Glycerol was added to the supernatant to a final 
concentration of 10% (v/v), then batch purified with 200 µl of anti-FLAG M2 affinity 
resin (Sigma) overnight at 4 °C.  The affinity resin was washed 5 times in wash buffer 
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10mM MgCl2 , 1 mM PMSF) then eluted in 
elution buffer (wash buffer with 200 µg/ml of FLAG peptide).  Protein samples were 
used immediately after purification.  Protein concentrations were determined by 
measuring absorbance at 280 nm.  Protein purity was assessed by PAGE and Coomassie 
brilliant blue staining. 
 
Native Gel Analysis 
Native gels were run as described previously 20.  Briefly, purified Itk constructs 
were mixed in a 1:1 ratio with native gel loading dye. BSA (10 ng) was loaded as a 
standard.  A protein concentration of 1.9 µM in a volume of 10 µL was loaded for the 
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following constructs: KD, LKD, and 2LKD.  A protein concentration of 31 µM in a 
volume of 10 µL was loaded for the following constructs: SH3-SH2, SH3BtkSH3-SH2, and 
SH3-SH2 (I282A).  A protein concentration of 5 µM in a volume of 10 µL was loaded 
for the following constructs: 32KD and 32KDBtkSH3. The proteins were loaded on a 12% 
discontinuous native gel and run at 180V with Tris Cl pH 8.8 as the running buffer.  The 
gels were then stained with Coomassie stain.   
 
Modeling in Xplor-NIH 
 The modeling of the SH3-SH2 dual domain fragment complex was performed in 
Xplor-NIH 21 and PyMOL 30.  The Itk SH3-SH2 fragment was generated by linking the 
SH3 domain from the average minimized SH3/SH2 complex 16 (pdbcode 2k79) to the 
SH2 domain from the average minimized SH3/SH2 complex.  Two unminimized SH3-
SH2 fragments were then aligned to the SH3/SH2 complex to generate a starting 
structure.  Simulated annealing was performed on the starting structure keeping the 
individual domain structures rigid and the SH3/SH2 interaction fixed.  The seven-residue 
linker (229-335) between the SH3 and SH2 domains was flexible during simulated 
annealing.   
 
Figures Captions 
Figure 1 
List of all constructs used in the biophysical characterization of Itk followed by their 
corresponding domain structure and molecular weight in kiloDaltons.  The domain 
structure also contains the beginning and ending residue number for each construct.  In 
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gray are the chimera constructs that replace the Itk SH3 domain with the Btk SH3 
domain.  In cyan is the single point mutation of the SH2 domain, I282A. 
Figure 2 
Native gel analysis of Itk constructs.  The first lane in each panel contains BSA as a 
control.  Additionally, the left panel contains wild type SH3-SH2 and mutants SH3-SH2 
(I282A) and SH3-SH2 (Btk SH3).  The middle panel contains wild type 32KD and 
mutant 32KD (Btk SH3).  The right panel contains wild type Itk fragments 2KD, LKD, 
and KD.   
Figure 3 
Cartoon representation of the Itk SH2 and SH3 domains.  Secondary structure is colored 
green, yellow, and red, for loop, strand, and helix. The SH2 and SH3 domains in the 
binary complex are circled yellow and blue respectively.  a) Structure of the Itk SH3/SH2 
complex. b) Structure of the SH3-SH2 fragment that was generated in PyMOL by linking 
the individual structures sequentially N-C terminally.  c) Starting structure for simulated 
annealing after aligning SH3-SH2 fragments to the SH3/SH2 binary complex.  
Figure 4 
a) Ensemble structure of the 20 lowest energy structures following simulated annealing 
are contained within a region of space (represented as trapezoids) that excludes the 
possibility of both SH3 and SH2 domain interactions being occupied at the same time. 
The SH2 and SH3 domains in the binary complex are circled yellow and blue 
respectively.  b) The cartoon domain structure of the Itk SH3-SH2 fragment as a dimer.  
c) One of the 20 lowest energy structures from the ensemble from 4a. 
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Figure 5 
Surface representation of the Itk SH2 domain shown in green.  The interaction surfaces 
SH2/SH3 and SH2/kinase are shown in blue on the left and red in the middle 
respectively.  The overlap of the two surfaces is shown in purple on the right. 
 
Figure 1 
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CHAPTER 6.  STRUCTURAL MODEL OF ITK 
AUTOPHOSPHORYLATION 
 
A collection of unpublished data 
 
Abstract 
 
 Changes in the quaternary structure of multidomain proteins are emerging as a 
mechanism of regulation in biochemical signaling pathways.  Autophosphorylation in 
Tec family kinases is one example of a regulatory post-translational modification that is 
dependent on the conformation of its quaternary structure.  Interleukin-2 tyrosine kinase 
of the Tec family autophosphorylates Y180 in its own SH3 domain and is dependent on 
the presence of the adjoining SH2 domain.  We previously identified a surface on the 
SH2 domain that is required for Itk autophosphorylation1.  The SH2 domain, through this 
surface, docks onto the kinase domain facilitating SH3 domain autophosphorylation.  
Here, we present a structural model of Itk autophosphorylation based on a previous point 
mutational analysis of the Itk SH2 domain coupled with covalent bond restraints provided 
by the linkers of the SH3-SH2-kinase fragment of Itk. 
 
Introduction 
 
With the solution of the human genome 2 along with many other genomes3; 4; 5; 6, 
the number of protein structures available for structural analysis has increased 
dramatically.  Along with this increase in individual protein sequences is an increase in 
the number of protein-protein interactions available for structural analysis.  A significant 
portion of these protein-protein interactions is expected to have weak binding affinity.  
However, an inspection of the pdb database reveals that only a few weak binding protein-
protein interactions have been solved to date 7  It is more challenging to solve weak 
binding complexes than strong binding complexes due to limitations of the two main 
techniques used for determining a protein structure, NMR and X-ray crystallography.  
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Fortunately, new NMR based methods have been developed to overcome some of these 
challenges 8.  Conjoined rigid-body/torsion-angle simulated annealing using residual 
dipolar coupling (RDC) restraints and ambiguous NOE restraints derived from 1H,15N 
chemical shift perturbation maps is described in detail elsewhere 9.  This technique 
overcomes the time intensive process of acquiring and analyzing NOE data for the 
identification of unambiguous intermolecular NOE restraints through the efficient 
acquisition and generation of orientation and translation restraints. 
RDC restraints are referred to as orientation restraints8.  The dipolar coupling 
between two nuclei depends on the orientation the bond vector makes with respect to the 
main magnetic field.  Under isotropic conditions, the dipolar coupling constant tends to 
zero and is unobservable.  This is overcome by the addition of alignment medias 10; 11; 12; 
13; 14 that induce a partial or residual alignment of the proteins in an NMR sample.  This 
partial alignment results in a residual dipolar coupling constant that is measurable using 
2D NMR experiments 8; 15.  Since RDC restraints provide orientation information on the 
bond vector formed between two nuclei with respect to the main magnetic field, these 
restraints can be used to orient bond vectors with respect to each other.  In a protein-
protein complex, this technique provides orientation information of bond vectors in both 
proteins effectively orienting the two proteins with respect to each other 10. 
Translational restraints can be obtained from chemical shift perturbation mapping.  
A heteronuclear single quantum coherence (HSQC) spectrum has long been the 
workhorse of NMR spectroscopy16.  Each 2D crosspeak corresponds to a specific N-H 
group in the protein.  The location of the peak depends on the local chemical 
environment, which determines the frequency at which the nitrogen and hydrogen atoms 
resonate.  If the local chemical environment is perturbed by the addition of a ligand or 
protein binding partner the resonance frequency of the 2D crosspeak will change 
correspondingly.  If the chemical shift perturbations are assigned by their corresponding 
residue and mapped onto a protein structure, the binding surface of the protein-protein 
interaction can be identified.  The binding surface for each protein can be identified in 
turn and ambiguous NOE restraints can be generated using these surfaces 9.  Together, 
 
 
124 
chemical shift perturbation derived ambiguous NOE restraints with RDC restraints create 
a powerful tool for solving protein-protein interactions. 
 There are more challenges in protein structure determination that still need to be 
overcome.  In some of these challenges, NMR and X-ray crystallography are inadequate 
to obtain a structural model efficiently: large size, weak binding affinity, multiple 
transient conformations.  Determining different conformational states of the quaternary 
structure found in multi-domain proteins is one of these challenges.  Domain-domain 
orientation using RDC restraints solves part of this problem but is limited by the size of 
the proteins that can be studied 10. 
Understanding specific docking mechanisms found in kinase substrate recognition 
would greatly benefit from a new technique that could provide structural information on 
protein domain quaternary structure17; 18; 19; 20.  A docking interaction is defined as a 
direct interaction between a site on the kinase domain (remote from the active site) and a 
complementary site on the substrate (remote from the phosphorylation site) 17; 19.  
Docking modules are well characterized in serine/threonine kinases and consist of short 
peptide motifs such as the D box of MAPK substrates and the DEF domain of ERK 
substrates 17; 19; 20.  While substrate docking interactions are well known in 
serine/threonine kinases, they have been less well characterized in tyrosine kinases with 
only two examples described to date: C-terminal Src kinase (Csk) and Tec family kinases 
21; 22; 23; 24.  
Structural insight into the Itk SH2/kinase docking can be obtained using a new 
method that uses restraints that are analogous to chemical shift perturbations and RDC 
restraints.  Here, we describe how the biochemical method of point mutational analysis 
coupled with covalent bond restraints provided by linker residues between domains can 
be used to generate a structural model of Itk autophosphorylation. 
 
Results 
 
We previously reported a substrate docking mechanism for the Tec kinase family 
(Itk, Btk, Tec, Bmx and Txk) 21.  Using Itk as a model system, previous experiments 
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showed that Itk autophosphorylation within the Itk SH3 domain (specifically on Y180) is 
dependent on the presence of the neighboring Itk SH2 domain 21.  During 
autophosphorylation, the Itk SH2 domain directly binds the Itk kinase domain via a non-
canonical interaction that does not involve the phosphopeptide binding pocket of the Itk 
SH2 domain, positioning the substrate (Itk SH3 Y180) into the active site of the Itk 
kinase domain (Fig. 1) 21.  Previous point mutation experiments identified residues that 
mediate the substrate docking interaction between the SH2 domain and kinase domain.  
The set of residues identified on the Itk SH2 domain is critical for docking the Itk SH2 
domain onto the Itk kinase domain and mediating Itk SH3 domain phosphorylation (Fig. 
2).  While the docking surface on the Itk SH2 domain was identified by point mutational 
analysis,1 the complimentary docking surface on the kinase domain remains unknown. 
 We have generated a preliminary model for substrate docking in the context of Itk 
autophosphorylation that provides a structural context to provide guidance as we move 
toward mutagenesis of the Itk kinase domain itself.  In developing the model, we took 
into consideration two previously published observations: (1) autophosphorylation of 
Y180 in the Itk SH3 domain occurs via an intramolecular interaction (in cis), where the 
Itk kinase domain phosphorylates the SH3 domain within the same polypeptide chain 25, 
and (2) contacts between W355 in the Itk SH2-kinase linker and M410 in the C-helix of 
the Itk kinase domain are critical for Itk kinase activity 25.  To first generate a model of 
the kinase domain bound to the SH3 domain, the Itk kinase domain was aligned with the 
Insulin receptor kinase (Irk) domain within the Irk:peptide substrate complex 26, and 
Y180 within the Itk SH3 domain was aligned with the tyrosine of the Irk peptide 
substrate in the active site (Fig. 3A).  Once aligned, the Itk SH3 domain fits well into the 
Itk kinase active site and no further structural rearrangements are necessary.   
 In the context of full length Itk, the SH2 domain lies between the SH3 and kinase 
domains and is tethered to the Itk SH3 domain at its N-terminus and to the SH2-kinase 
linker at its C-terminus.  Using these covalent constraints and the SH2-kinase linker 
location 21 as an additional restraint, we modeled the possible docking sites of the Itk SH2 
domain on the surface of the Itk kinase domain using Xplor-NIH 27.  To represent the 
possible locations in which the Itk SH2 domain may dock onto the Itk kinase domain 
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surface during autophosphorylation, the Itk kinase domain was arbitrarily divided into 
four quadrants, with the x and y axes intersecting within the kinase active site as shown 
(Fig 3A). From 100 energy minimized model outputs, it is evident that the SH2 domain 
clusters primarily within quadrant two on the Itk kinase domain, with slight overlap into 
quadrant three (Fig 3B). Docking of the Itk SH2 domain onto the Itk kinase quadrants 
one and four are unlikely (assuming no major changes in the Itk SH2 and SH3 secondary 
structure) due to the restraints imposed by the SH3-SH2 and SH2-kinase linker lengths.  
Although the SH2 domain clusters to quadrant two on the kinase domain, without further 
restraints it shows no preferred orientation with respect to the kinase domain, freely 
rotating about the SH3-SH2 and SH2-kinase linkers.   
 To further refine the putative docking surface on the Itk kinase domain, all surface 
kinase residues within 3 Å of the Itk SH2 domain cluster were selected. These surface 
exposed kinase domain residues form a contiguous surface (Fig. 3C) that represents, for 
modeling purposes, the overall accessible docking surface for the Itk SH2 domain on the 
Itk kinase domain (Fig. 3B).  The corresponding SH2 docking surface is defined by the 
mutational experiments presented in Figure 2.   Using the kinase and SH2 surfaces 
defined in this way, we generated restraints for further simulated annealing in a manner 
that is analogous to the use of chemical shift perturbation mapping data 9. 
 A representative model of the Itk SH3-SH2-kinase fragment undergoing SH2-
mediated autophosphorylation on Y180 is shown in Figure 4A.  In this model, the Itk 
SH2 domain contacts both the N and C-terminal lobes of the Itk kinase domain in a 
position that is orthogonal to the substrate SH3 domain.  Moreover, the phosphopeptide 
ligand-binding surface of the Itk SH2 domain remains largely accessible during 
autophosphorylation.  To visualize the SH2 ligand binding site, a bound phosphopeptide 
28 is superimposed onto the modeled structure in Fig. 4A.  As expected, for the dual 
domain SH3-SH2 fragment we find that the SH2 side chains that mediate contacts to the 
kinase domain (Fig. 2) are located on the same side as Y180 within the SH3 domain (Fig. 
4B).  Additionally, we find that the Itk SH3-SH2 domain fragment in the modeled 
structure is remarkably similar to the previously reported crystal structure of the 
corresponding Lck SH3-SH2 dual domain fragment (Fig. 4B).   Specifically, the relative 
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orientations of the SH3 and SH2 domains in the experimentally solved Lck structure and 
the modeled Itk arrangement are almost the same and the linker between the domains 
follows a similar trajectory between SH3 and SH2 domains.  While the model generated 
here is certainly useful to visualize how SH2 docking might be mediating Itk 
autophosphorylation, future mapping experiments to identify the precise binding site on 
the kinase domain and crystal structures of Itk kinase/substrate complexes will ultimately 
be needed to reveal the details of these interactions. 
 
Discussion 
 
 Unlike the method for solving protein-protein complexes that relies on chemical 
shift perturbation mapping and RDC restraints, the technique presented here uses a 
surface derived from a biochemical point mutational analysis of the SH2 domain.  The 
corresponding surface on the kinase domain in which the SH2 domain docks was 
identified from the conformational space determined from simulated annealing given the 
distance and orientation restraints inherent in the covalent bond structure of the linker 
residues between the SH3 and SH2 and between the SH2 and kinase domains.  The 
success of this technique strongly depends on these linker lengths.  Had the linker length 
between the SH3 and SH2 domain been much longer the location of the SH2 domain 
would not have been restricted to a particular quadrant and surface on the kinase domain 
(Figure 4).  Despite this limitation, this method is a useful tool for the structural analysis 
of quaternary structure found in multi-domain proteins. 
 Introducing mutations into the Itk kinase domain to identify the docking site for 
the SH2 domain would require extensive characterization since point mutants in the 
kinase domain can drastically affect catalytic activity 25.  However, the structural model 
presented here provides a useful tool to target residues in the kinase domain that are 
likely to be involved in the docking interaction.  A visual inspection of the Itk 
autophosphorylation structural model reveals 11 residues on the kinase domain that 
would make good candidates for mutational analysis: V365, Q366, E367, S370, L375, 
H377, D444, R447, R450, I556, and E559 (Fig 5).  This is a significant improvement 
 
 
128 
over the 30-residue surface that was identified for use in ambiguous NOE restraints 
during the SH2/kinase docking simulated annealing.  The 11 residues form two discrete 
surfaces, one on the N-terminal lobe and one on the C-terminal lobe of the Itk kinase 
domain (Fig 5).  The results of this point mutational analysis will provide information 
concerning the accuracy of our model (Fig 4) and will narrow down the surface residues 
on the kinase domain involved in SH2 domain docking.  Although a crystal structure of 
the Itk autophosphorylation conformation would be ideal to answer structure related 
questions about Itk docking during autophosphorylation, the transient nature of this 
conformation will be challenging to solve by X-ray crystallography.  However, once the 
complementary surface on the kinase domain has been identified through point 
mutational analysis directed by this preliminary model, a refined model of the structure of 
Itk autophosphorylation can be generated in Xplor-NIH using ambiguous NOE restraints 
derived from the SH2 and kinase domain surfaces.  The technique described here 
provides a useful tool to investigate transient structural conformations of multidomain 
proteins. 
 
Methods  
 
 A model of the complex of the Itk kinase domain (PDB ID 1SNX) bound to the 
Itk SH3 domain (PDB ID 1AWJ), was generated by first aligning the Itk kinase domain 
with the kinase domain of the Insulin receptor kinase (Irk) using the structure of the 
Irk:peptide substrate complex (PDB ID 1IR3).  Y180 in the Itk SH3 domain was then 
superimposed with the tyrosine of the Irk peptide substrate.  Additionally, mutagenesis 
we have previously shown that the active conformation of the Itk kinase domain requires 
both W355 in the Itk SH2-kinase linker region and M410 in the Itk kinase C-helix 25 in a 
manner that mirrors Csk 29. Itk W355 is not present in the Itk kinase domain structure 
(PDB ID 1SNX) and so the Itk kinase domain (with SH3 in its active site) was next 
aligned with the full-length Csk tyrosine kinase structure (PDB ID 1K9A) to model the 
position of Itk W355 25.  Once aligned, both the Itk SH3:kinase complex as well as Itk 
W355 were held fixed during subsequent calculations. 
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The Itk SH3-SH2-kinase single polypeptide chain was generated by linking the 
Itk SH2 domain (PDB ID 1LUK) to the appropriate termini in the modeled Itk 
kinase:SH3 complex described above.  Intervening residues in the Itk SH3-SH2 linker 
and the SH2-kinase linker regions that are not included in the deposited structures of each 
of the domains were built using PyMOL 30.  The starting position of the Itk SH2 domain 
was primarily dictated by the short linker between the SH3 and SH2 domains in Itk.  
 Simulated annealing was performed using Xplor-NIH (using the refine.py script 
without any additional user defined restraints) 27 on the Itk SH3-SH2-kinase fragment 
built as described above.   The backbone atoms for the Itk SH3, SH2 and kinase domains 
were kept rigid, while the linker between the SH3 and SH2 domains (residues 228-236) 
and the linker between the SH2 and kinase domains (residues 339-354) were allowed to 
be flexible. This initial simulated annealing step generated an ensemble of 100 structures.   
 Using the ensemble of 100 structures generated as described above, all surface 
exposed residues on the Itk kinase domain that are located within 3 Å of the Itk SH2 
domain were selected in PyMOL.  The resulting surface represents the putative substrate-
docking surface on the Itk kinase domain.   
The Itk SH2 domain-docking surface is defined by previous mutational 
experiments on the SH2 surface that resulted in a significant loss in phosphorylation of 
Itk SH3-SH2 fragment 1; 21.  We next treated these complementary protein surfaces (on 
the SH2 and kinase domains) in a manner analogous to chemical shift perturbation maps.  
Highly ambiguous NOE restraints 9 were generated between the kinase and SH2 surfaces 
and incorporated into a second round of simulated annealing.    
 Simulated annealing using the single polypeptide chain (SH3-SH2-kinase) 
resulted in models that did not properly satisfy the majority of the ambiguous NOE 
restraints (hereafter referred to as ambiguous restraints).  Therefore, we carried out the 
modeling in two separate steps.  We first carried out the simulated annealing to 
incorporate the ambiguous restraints using only the SH3-SH2 (residues 171-338) and 
kinase domains (355-618); the SH2-kinase linker was excluded. 68 structures were 
generated that satisfied the ambiguous restraints.  The structural models were sorted into 
two ensembles (cluster I and cluster II) based on structural similarity (5 Å backbone 
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RMSD (Fig 6).  Inspection of clusters I and II reveals that the SH2 residues identified by 
mutational analysis (Fig. 4) are in closer proximity to the Itk kinase domain in cluster I 
(Fig 6A) compared to cluster II (Fig 6B).  Secondly, in cluster II the average distance 
between the C-terminus of the SH2 domain and the N-terminus of the kinase domain is 
greater than the length of the extended SH2-kinase linker region.  Conversely, for cluster 
I the length of the SH2-kinase linker region is sufficient to span the distance between the 
C-terminus of the SH2 domain and the N-terminus of the kinase domain.  Finally, the 
total energies derived from the simulated annealing calculation were positive for the 
structural models in cluster II (average energy = 717 kcal/mol) and negative (average 
energy = -568 kcal/mol) for the structural models in cluster I.  We therefore used the 
ensemble of 27 structures in cluster I to calculate an average structure for subsequent 
calculations. The SH2-kinase linker (residues 339-354) was re-introduced and allowed to 
collapse into an energetically feasible configuration, while the Itk SH3, SH2 and kinase 
domains (including W355) were held rigid.  The final model (Fig. 4A) is the average 
structure calculated from 16 structures resulting from this last simulated annealing 
procedure (Fig 7). 
 
Figure Captions 
 
Figure 1: Tec kinases mediate SH3 domain autophosphorylation via a conserved surface 
on the SH2 domain.  (A) Domain architecture of full-length Itk (residues 1-619), with a 
Pleckstrin homology (PH), Tec homology (TH), SH3, SH2 and kinase domain.  The 
autophosphorylation site (Y180) is located within the Itk SH3 domain.  (B) Schematic 
representation of Itk SH3 domain autophosphorylation.  Autophosphorylation on Y180 of 
the SH3 domain occurs ‘in cis’ and a direct binding interaction between the Itk SH2 
domain and the Itk kinase domain is necessary for Itk SH3 domain phosphorylation 21. 
 
 
Figure 2: Mapping of the Itk SH2 domain residues involved in Itk kinase docking onto 
the domain structure.  (A) The Itk SH2 domain residues that were mutated in the previous 
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study are mapped onto the structure of the Itk SH2 domain (shown in cyan, PDB ID 
1LUN).  Residues that, upon mutation, disrupt autophosphorylation on SH3 Y180 are 
shown in red.  Surface rendering of the Itk SH2 domain bound to its classical 
phosphotyrosine containing peptide 28.  The phosphopeptide is shown in orange with the 
phosphotyrosine (pY) and proline residue in the pY+3 position included as sticks and 
labeled.  The red surface of the SH2 domain is comprised of those residues mapped by 
mutation that mediate phosphorylation of Y180.  This substrate-docking surface is circled 
on both. 
 
Figure 3: Proposed docking surface on the Itk kinase domain of the Itk SH2 domain.  (A) 
The Itk kinase domain structure (shown in blue, PDB ID 1SNX) was aligned with the 
structure of the substrate-bound insulin receptor kinase domain (PDB ID 1IR3).  For 
clarity, the insulin receptor kinase substrate bound structure is not shown.  The Itk SH3 
domain (grey ribbon) was docked into the Itk kinase domain active site by superimposing 
Itk Y180 (represented by sticks in red) with the tyrosine residue of the insulin receptor 
kinase substrate.  The Itk kinase domain is arbitrarily divided into four quadrants with the 
x and y axes intersecting within the active site of the kinase domain. The Itk SH2 domain 
(represented by the orange oval) is covalently linked to the Itk SH3 domain and the Itk 
kinase domain via its N- and C-termini, respectively. The domain structure of the SH3-
SH2-Kinase fragment of Itk is shown as a schematic below the structural depiction.  (B) 
Ensemble of the putative Itk SH2-kinase docked models.  Simulated annealing was 
performed on the Itk SH3-SH2-kinase fragment using Xplor-NIH by taking into account 
the constraints imposed by the N- and C-termini of each individual domains, the SH2-
kinase linker (brown line) and SH3-SH2 domain linker (green line) lengths and a distance 
restraint between W355 within the Itk SH2-kinase linker and M410 within the C-helix of 
the kinase domain.  An ensemble of 100 structures was generated that were clustered into 
12 groups based on their structural similarity (5 Å backbone RMSD) and a representative 
structure from each of the 12 groups is shown in the superposition. The Itk SH2 domain 
clusters mainly to quadrant two on the Itk kinase domain.  (C) The putative docking 
surface on the Itk kinase domain was identified by selecting surface exposed residues 
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(orange sticks) on the Itk kinase domain within 3 Å of the Itk SH2 docked ensemble in 
Fig. 3B.  
 
Figure 4: Model of the Itk kinase domain docked with the Itk SH2 domain.  (A) 
Structural model showing the possible docking configuration of the Itk SH2 domain with 
the Itk kinase domain during SH3 autophosphorylation.  The kinase domain (blue) is 
oriented with the active site facing the viewer.  Y180 (red) of the SH3 domain (black) is 
labeled and pointing into the active site.  The linker between SH3 and SH2 is green and 
the linker between SH2 and kinase is brown; both are labeled.  The phosphopeptide 
ligand-binding surface on the Itk SH2 domain remains accessible in this model of the 
docked SH2 domain.  To illustrate this point, a bound phosphopeptide is added (based on 
PDB ID 2ETZ) to the model and depicted in red; the pY and pY+3 residues are labeled.  
The docked SH2 domain in this model contacts both the N- and C-terminal lobes of the 
Itk kinase domain.  (B) Structural comparison of the Lck SH3-SH2 dual domain structure 
(shown in tan, PDB ID 1LCK) solved by crystallography (bottom), with the Xplor-NIH 
generated model of the Itk SH3-SH2 domain (top).  The Itk SH2 residues that mediate 
Y180 phosphorylation are depicted in red as is Y180 on the SH3 domain.  The standard 
secondary structural elements for the SH3 and SH2 domains are indicated to illustrate the 
similarity in the relative domain orientations.  All structure figures were generated using 
PyMol 30. 
 
Figure 5: Cartoon representation of the SH2 domain (orange) docked onto the kinase 
domain (blue).  The green surface represents residue candidates for point mutation 
analysis identified by visual inspection of this model.  On the left, is the model of Itk 
autophosphorylation.  On the right, the model is rotated 45° and the SH2 domain is 
removed for visual clarity.  Interestingly, these residues span both the N and C-terminal 
lobes of the kinase domain. 
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Figure 6:  Simulated annealing of ambiguous NOE restraints between the surface 
identified on the SH2 domain through mutation and the surface on kinase domain 
identified from the allowed conformational space in the previous simulated annealing 
run.  The ensemble of structures clustered into two energy minimums.  A) Cluster I, 
average energy of this cluster is -568 kcal/mol.  B) Cluster II, the average energy of this 
cluster is 717 kcal/mol 
 
Figure 7: In this figure the ensemble output of the final simulated annealing calculation 
that includes the SH2-kinase linker is represented.  There are 16 structures in the 
ensemble.  The SH2-kinase linker finds several paths to join the C-terminus of the SH2 
domain with the N-terminus of the kinase domain due to the lack of linker restraints.  
This ensemble confirms that the linker between the SH2 and kinase domains is long 
enough to form an energetically feasible conformation for cluster I identified in the 
previous simulated annealing run. 
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CHAPTER 7.  GENERAL SUMMARY AND CONCLUSIONS 
 
Summary 
 Interleukin-2 tyrosine kinase (Itk) is a five-domain containing non-receptor tyrosine 
kinase important in proper T-cell signaling and immune response to T-cell receptor 
stimulation.  Itk is a member of the Tec family of kinases, which share a common feature 
of self-association believed to be important in regulation and cell signaling 1; 2.  We 
previously reported an intermolecular self-association for Itk through its SH2 and SH3 
domains 3; 4.  However, the structural details behind this interaction were unknown at that 
time.  One technique that has been successful in determining protein-protein interactions 
is conjoined rigid body/torsion angle simulated annealing 5; 6.  This technique however, 
assumes that the starting structures are of high quality.  To this end, I solved, to high-
resolution, NMR solution structures of the Itk SH3 domain and refined to higher-
resolution the structure of the Itk SH2 domain 7.  These structures also provided high 
quality unbound structures for comparison with the structures of the SH3/SH2 complex 
also solved to high resolution in this dissertation.  This NMR structure is a good starting 
point for the understanding the self-association and signaling of Itk.  From this SH3/SH2 
complex structure, we now understand how isomerization of a proline imide bond acts as 
an intrinsic molecular switch that preorganizes the CD loop of the SH2 domain for a non-
classical interaction with the SH3 domain (Chapter 4, Figure 4)8. The structure also 
provides insight into how autophosphorylation in the Itk SH3 domain might increase the 
affinity of the intermolecular SH3/SH2 interaction (Chapter 4, Figure 6).  Since the 
SH3/SH2 interaction does not require the classical binding ligands for the SH3 and SH2 
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domains, the SH3/SH2 structure reveals a greater binding diversity of these small domains 
than previously known.  In due course, the intermolecular Itk SH3/SH2 interaction must 
be understood in the context of the full length Itk protein (Chapter 4, Figure 7).  Hence, 
preliminary experiments were performed to characterize the oligomeric state of Itk self-
association and use the SH3/SH2 domain complex as a starting point to generate a 
structural model for Itk self-association that accounts for the oligomerization seen during 
biophysical characterization (Chapter 5, Figure 4).  Native gel analysis suggests there 
exists another intermolecular interaction in the SH2-kinase fragment of Itk that requires 
further investigation (Chapter 5, Figure 2).  The interaction surface on the SH2 domain 
that leads to the SH3/SH2 oligomerization has also been reported to be involved in Itk 
autophosphorylation 9; 10 (Chapter 5, Figure 5).  Since these two events appear to be 
mutually exclusive, the structural model of Itk autophosphorylation was generated using 
a previous point mutational analysis of the Itk SH2 domain coupled with covalent bond 
restraints found in the linkers of the SH3-SH2-kinase fragment (Chapter 6, Figure 4A).  
These studies bring us closer to understanding the structural mechanism behind Itk self-
association and describe a model for one of the many quaternary structural conformations 
in which Itk is likely to exist. 
 
Biological Context 
The SH2 and SH3 domains are found in a multitude of multidomain proteins and 
they are well known as a targeting mechanism required for cellular signaling 11; 12; 13; 14.  
This dissertation extends our understanding of these small domains and highlights 
another important role in regulating the oligomeric state and the quaternary conformation 
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in multidomain proteins.  So how does the information presented here fit into the larger 
picture of Itk regulation and signaling.  A closer inspection of the three main steps of 
activation of Itk (1. localization of Itk to the membrane, 2. association with an adaptor 
protein complex, and 3. transphosphorylation by Lck) 15 suggests a possible model of 
signaling that incorporates the oligomerization of Itk through the SH3/SH2 interaction 
discussed in this dissertation (Figure 1). T-cell receptor stimulation results in an increase 
in PIP3 concentrations leading to the first step of activation, Itk localization to the 
membrane through an interaction of the PH domain with PIP3.  Evidence in the literature 
supports oligomerization at the membrane following TCR stimulation 16. 
 
 
Figure 1: Model of Itk Signaling. 
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Although the exact point of oligomerization following TCR stimulation is to be 
determined, the model I propose suggests that following recruitment to the membrane Itk 
forms an oligomer permitting higher concentrations of Itk to be localized to the TCR 
(Figure 1:step 1).  The interaction between the Itk SH3 and SH2 domains is weak 
compared to the binding affinity with the adaptor protein complex (SLP-76/LAT) 4; 9.  
Since both the Itk SH2 and SH3 domains bind SLP-76 15, it is likely that individual 
molecules of Itk bind the adaptor complex in the second step of activation of Itk.  At this 
point Itk can be phosphorylated by Lck (Figure 1, step 2), the last step in Itk activation, 
leading to Ca2+ mobilization, transcription, and cytokine release important in proper 
immune response (Figure 1, step 3).   
Active Itk then undergoes autophosphorylation (Figure 1, step 4).  This signaling 
step requires Itk to change its quaternary structure in which the SH2 domain docks onto 
the kinase domain placing the SH3 domain into the active site of the kinase domain 
(Chapter 6, Figure 4A).  This conformational change in quaternary structure, and the 
decreased affinity between the phosphorylated SH3 domain and SLP-76 and an increased 
affinity between the SH3 and SH2 domains in Itk 9 likely results in the reformation of the 
oligomeric state.  This oligomer, however, may sequester the Itk molecules in what can 
be viewed as the first step toward the inactivation of T-cell receptor response.  This 
signaling model accounts for the increase in kinase activity for the ItkBtkSH3 mutant in 
which the interaction between the SH3 an SH2 domains has been disrupted (unpublished 
data of L. Min and W. Wu).  The model of Itk oligomerization fits well with what is 
known about Itk self-association and Itk autophosphorylation as supported by the 
literature.  However, it is incomplete without a better understanding of the contribution of 
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the other known intermolecular interactions that promote self-association of Itk and a 
better structural understanding of the many conformational states in which Itk likely 
exists.  Further study of these interactions will need to be explored to better understand 
the exact role oligomerization and quaternary structure has in Itk signaling.  This 
dissertation provides a significant contribution toward understand intermolecular self-
association and quaternary structure of Itk and provides the groundwork for continued 
research efforts toward understanding the role oligomerization and quaternary structure 
has in Tec family kinase signaling and regulation. 
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APPENDIX 1.  POINT MUTATIONS 
 
 
This appendix includes a list of all point mutation on the Itk SH3 and SH2 domains to 
date. 
 
 
Number Date 
15N 
labeled Unlabeled Kd Lower bound 
Upper 
bound 
1 3/29/07 SH2 SH3Y180E 0.11     
2 2/20/08 SH3E189Q SH2 2.05 1.65 2.47 
3 3/7/08 SH3Y180E SH2K280A 1.10 0.98 1.24 
4 4/10/08 SH3E189R SH2R332E   
too weak to 
determine   
5 4/12/08 SH2R332A SH3 1.80 1.69 1.90 
6 4/22/08 SH3V227T SH2 0.58 0.41 0.76 
7 4/23/08 SH3H207P SH2   isomerizes   
8 5/5/08 SH3S224N SH2 2.80 2.54 3.05 
9 6/12/08 SH2K309E SH3E189K 1.09 0.95 1.22 
10 6/12/08 SH2R332D SH3D186R   
too weak to 
determine   
11 7/2/08 BtkSH3 ItkSH2   
too weak to 
determine   
12 11/9/08 SH3 SH2 0.44 0.37 0.51 
13 11/9/08 SH3 SH2K309E 1.85 1.65 2.06 
14 11/19/08 SH3N185E SH2 0.48 0.42 0.53 
15 11/19/08 SH3 S1/S2 SH2   
too weak to 
determine   
16 11/19/08 SH3 S2/S3 SH2   unfolded   
17 11/19/08 SH2I282A 
SLP-76 
pep 1.00 0.82 1.20 
18 1/17/09 SH3S224A SH2 0.40 0.07 0.74 
19 1/17/09 SH3H207F SH2 0.25 0.10 0.38 
 
S1= N185M D186N Q188N E189D   
S2= L226V S224N V227T   
S3= E205N I206L   
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APPENDIX 2.  SCRIPTS 
 
This appendix includes a list of scripts that were useful toward the completion of my 
degree. 
 
1awjSS.py 
#This python script will redraw the secondary structural elements of a protein.  This 
program  
#is set up for the protein with pdbcode 1AWJ. 
import sys 
from pymol import cmd 
 
cmd.alter("223-227/", "ss='H'") 
cmd.alter("179-185/", "ss='S'") 
cmd.alter("190-194/", "ss='S'") 
cmd.alter("218-221/", "ss='S'") 
cmd.alter("208-212/", "ss='S'") 
cmd.alter("199-203/", "ss='S'") 
cmd.rebuild() 
cmd.cartoon("automatic") 
cmd.show("cartoon") 
 
 
multialign.py 
#This python script can be used to align multiple structures to the same structure. 
 
import sys 
from pymol import cmd 
f 
 
for i in cmd.get_names('objects'):  
           cmd.align('%s'%(i),'proteinname and resi selection') 
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findandreplace 
 
#!/usr/bin/env perl 
 
#I found this script to be useful in removing a comment in a pdb file.  
 
open(infile, @ARGV[0]) or die "can't open it"; #opens a file and assign it to infile 
open(outfile, ">new.pdb") or die "can't open it"; 
 
 
$i=0; 
while(<infile>){ 
 
#These lines sequentially identify ! and comments of multiple lengths then replaces 
#them with nothing 
 
$_=~s/!................../ /; 
$_=~s/!................./ /; 
$_=~s/!................/ /; 
$_=~s/!.............../ /; 
$_=~s/!............../ /; 
$_=~s/!............./ /; 
$_=~s/!............/ /; 
$_=~s/!.........../ /; 
$_=~s/!........../ /; 
$_=~s/!........./ /; 
$_=~s/!......../ /; 
 
#print $_; 
print outfile $_; 
$i++; 
}
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runprocheck 
 
#!/bin/csh 
 
#easily modified to run any program on a folder of files. 
foreach file (*.sa) 
procheck_nmr $file 
end 
more *.sum | egrep "Ramachandran plot" 
 
 
 
getpdb 
 
 
#!/bin/csh 
 
#this command allows one to download a pdb file using the 4 letter code 
#it downloads the file into the current working directory 
#getpdb #### 
 
wget ftp://ftp.rcsb.org/pub/pdb/data/structures/all/pdb/pdb$1.ent.Z 
gunzip pdb$1.ent.Z 
mv pdb$1.ent $1.pdb 
 
 
nb 
#!/bin/csh 
 
#short for notebook allows for the user in a terminal to make quick notes and write them  
#to a notebook found in the homedirectory 
 
if ( "$1" == 'n' ) then 
echo $2 >> ~/notebook.txt 
else 
if ( "$1" == "t" ) then 
tail -n 40 ~/notebook.txt 
else 
date >> ~/notebook.txt 
echo $1 >> ~/notebook.txt 
echo "" >> ~/notebook.txt 
endif 
endif 
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readme 
#!/bin/csh 
 
#this program is similar to the nb command and will generate a readme file in the  
#working directory.  A copy of the readme file is also sent to the notebook.txt in  
#the users home directory 
 
if ( "$1" == 'n' ) then 
echo $2 >> README 
echo $2 >> ~/notebook.txt 
else 
echo "" >> README 
date >> README 
echo $1 >> README 
echo "" >> ~/notebook.txt 
date >> ~/notebook.txt 
pwd >> ~/notebook.txt 
echo $1 >> ~/notebook.txt 
endif 
 
 
 
 
nbsearch 
 
#!/bin/csh 
 
#this script will allow the user to search the notebook found in the home directory 
if ( "$1" == "num" ) then 
more +$2 ~/notebook.txt 
else 
more ~/notebook.txt | grep --color -n -P -A 4 -B 4 $1 
endif
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xplor2FL 
#!/bin/csh 
 
#This scripts allows the user to modify the residue numbering of a pdb file 
set p=6 
set n=1 
while ($p<112) 
 
@ q = ($p + 228) 
#echo $n 
if ($n == 1) then 
sed s/"(resid $p "/"(resid $q "/g $1 > out2 
sed s/"(resid $p "/"(resid $q "/g $1 | egrep  "resid $q " 
@ n = ($n + 1) 
else 
sed s/"(resid $p "/"(resid $q "/g out2 > $1 
sed s/"(resid $p "/"(resid $q "/g out2 | egrep  "resid $q " 
@ n = ($n - 1) 
endif 
@ p = ($p + 1) 
end 
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pales2xplor 
#!/usr/bin/perl 
 
#this program is useful to convert the pales program outfile that calculates dihedral  
#angles from NMR chemical shifts into a restraint file readable by Xplor-NIH 
#the program the minimizes the restraints to produce a structure. 
 
print "palesoutputfile "; 
$fname = <STDIN>; 
open(INFILE, $fname); 
print "output "; 
$fname3 = <STDIN>; 
$n=0; 
 
 
while (<INFILE>) { 
        chop; 
        
($resid[$n],$resname[$n],$atomname[$n],$residj[$n],$resnamej[$n],$atomnamej[$n],$D
obs[$n],$Derr[$n],$Dweight[$n]) = split; 
 #      $rdc[$n] = -$rdc[$n]; 
        $n++; 
    } 
open(OUT,">$fname3");  
for ($i=0; $i<$n; $i++) { 
 
printf OUT "\n"; 
printf OUT "assign ( resid 500  and name 00  )\n"; 
printf OUT "assign ( resid 500  and name Z   )\n"; 
printf OUT "assign ( resid 500  and name X  )\n"; 
printf OUT "assign ( resid 500  and name Y   )\n"; 
printf OUT "assign ( resid $resid[$n]  and name N   )\n"; 
printf OUT "assign ( resid $resid[$n]  and name HN  )  $Dobs\n"; 
 
 
 
#printf OUT "%5.5f %5.5f\n", 
#        $Dobs[$i],$Ddiff[$i]; 
#printf "%5.5f %5.5f\n", 
#       $D[$i],$Dobs[$i];  
} 
         
close($fname3); 
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KdDetermination.m 
 
function [cspimportbest,cspimportorig]=KdDetermination(n,tit) 
%[xval,yval]=KdDetermination(n,’titration.dat’) 
%This is a Matlab program and requires the curve fitting toolbox 
%n is the number of titration points 
%titration.dat is described below 
%calculation of dissociation constant using input from cara rather than 
%nvj 
 
 
%******************* 
%importing titration data 
%fit function parameters 
 
fcsstart=.8          %final chemical shift is ideally 1. 
fcslowerbound=0 
kdstart=2            %in mM 
kdlowerbound=0.6     %in mM 
 
 
 
titimport=importdata(tit); 
%format as follows with values in mM columns are [protein] [ligand] 
%.4 0 
%.389 .1135 
%.3685 .3345 
%.348 .5678 
%.3284 .5678 
%.3091 1.0513 
%.265 1.6513 
%.2296 2.211 
%.1722 3.261 
 
%import csp data 
 
cspimport=importdata('out.tbl'); 
%format as follows 
%first line needs to be empty 
%280 H 10.16 10.17 10.18 10.19 10.20 10.22 10.24 10.25 
%280 N 130.26 130.27 130.29 130.30 130.31 130.33 130.36 130.37  
 
%extracting resnumber and label 
 
resnumbers=cspimport.textdata(:,1) 
reslabels=cspimport.textdata(:,2) 
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%kd determination 
 
x=titimport(1:n,2) 
P=titimport(1:n,1) 
 
 
%fit the protein dilution to the equation of a line to incorporate into 
the 
%kd fit 
 
[pf]=polyfit(x,P,1) %This estimates the protein concentration as a 
function of ligand concentration. 
figure(101) 
plot(x,pf(1)*x+pf(2)) 
title('protein concentration function estimate') 
hold on; 
plot(x,P,'ro') 
eval(['f1=fittype(''fcs*','(','(','(',num2str(pf(1)),'*x+',num2str(pf(2
)),')','+x+kd',')','-
','sqrt(','(','(',num2str(pf(1)),'*x+',num2str(pf(2)),')','+x+kd',').^2
','-
','4*x*','(',num2str(pf(1)),'*x+',num2str(pf(2)),')',')',')','/(2*','('
,num2str(pf(1)),'*x+',num2str(pf(2)),')',')''',')']) 
 
 
csplengthover2=length(cspimport.data(:,1))/2; 
cspnumofspec=length(cspimport.data(1,:)); 
 
 
kdconfbest=1.99 
kdconfidence=2; 
cspimportorig=cspimport.data; 
cspimportbest=cspimport.data; 
     
for i=1:csplengthover2; 
    j=i+csplengthover2;     
    cspHandN(i,:)=sqrt((cspimport.data(i,:)-
cspimport.data(i,1)).^2+((cspimport.data(j,:)-
cspimport.data(j,1))./5).^2); 
end 
 
yaverage=(cspHandN(i,:)-cspHandN(i,:))';%zeros 
yall=(cspHandN(i,:)-cspHandN(i,:))';%zeros 
 
coefaverage=0; 
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coefall=0; 
for i=1:csplengthover2 
     
     
    y=(cspHandN(i,:)./cspHandN(i,cspnumofspec))'; 
    %y=((cspHandN(i,:)-cspHandN(i,1))./(cspHandN(i,9)-cspHandN(i,1)))' 
    yaverage=yaverage+y; 
    yall(:,i)=y; 
    %y=((cspimport.data(i,:)-
cspimport.data(i,1))./(cspimport.data(i,9)-cspimport.data(i,1)))' 
resnumbers(i) 
[freres,err]=fit(x,y,f1,'StartPoint',[1.4,.05],'Lower',[0,.01]) %actual 
fitting function 
ci=confint(freres); %confidence interval 
coef=coeffvalues(freres); %km and final chemical shift values  
coefall(i)=coef(1); 
%final chemical shift will be above 1. where 1 is the last point in 
your 
%titration so depending on how far you went with the titration will 
%determine your final chemical shift value.   
coefaverage=coefaverage+coef(1); 
figure(1) 
       hold on; 
       plot(x,freres(x)./coef(1)); 
       hold on; 
       y=y./coef(1); 
       plot(x,y,'ro'); 
       hold on; 
% figure(i+1) 
%        hold on 
%        title(resnumbers(i)); 
%        plot(x,freres(x)./coef(1)); 
%        hold on; 
%        %y=y./coef(1); 
%        plot(x,y,'ko'); 
%        hold on; 
% % % % % figure(100) 
% % % % % plot(x,y,'ko'); 
% % % % % hold on; 
 end 
 
%  
% print('kdconfidencediff=') 
% kdconfidence=ci(2,2)-ci(1,2) 
% if kdconfidence<kdconfbest 
% kdconfbest=kdconfidence 
% freresbest=freres; 
 159 
% cspimportbest=cspimport.data 
% print('here'); 
% cspimport.data(1,:); 
% cspimport.data(1,:)=cspimport.data(1,:)+(rand(1,cspnumofspec)*.001); 
% cspimport.data(2,:)=cspimport.data(2,:)+(rand(1,cspnumofspec)*.005); 
% else 
% cspimport.data=cspimportorig; 
% print('here') 
% cspimport.data(1,:) 
% cspimport.data(1,:)=cspimport.data(1,:)+(rand(1,cspnumofspec)*.001); 
% cspimport.data(2,:)=cspimport.data(2,:)+(rand(1,cspnumofspec)*.005); 
% cspimport.data(1,:) 
% end 
%  
%  
% end %delta cspcenters 
% print('freres best') 
% freresbest 
% print('kdconfdiff') 
% kdconfbest 
% print('bestcspcenters') 
% cspimportbest 
% print('origcspcenters') 
% cspimportorig 
% print('best-orig') 
% cspimportbest-cspimportorig 
 
 
csplengthover2; 
yaverage=yaverage./(csplengthover2); 
coefaverage=coefaverage./(csplengthover2); 
 
print('this is the average') 
 
eval(['f2=fittype(''(','(','(',num2str(pf(1)),'*x+',num2str(pf(2)),')',
'+x+kd',')','-
','sqrt(','(','(',num2str(pf(1)),'*x+',num2str(pf(2)),')','+x+kd',').^2
','-
','4*x*','(',num2str(pf(1)),'*x+',num2str(pf(2)),')',')',')','/(2*','('
,num2str(pf(1)),'*x+',num2str(pf(2)),')',')''',')']) 
 
[freres,err]=fit(x,yaverage./coefaverage,f1,'StartPoint',[.8,.02],'Lowe
r',[0,.01]) %actual fitting function 
ci=confint(freres); %confidence interval 
coef=coeffvalues(freres) 
figure(3) 
coefall 
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for i=1:csplengthover2; 
     
    plot(x,yall(:,i)./(coefall(i)),'ko') 
     
    hold on 
end 
      hold on 
      title('average over all residues') 
      x=0:.1:6; 
      plot(x,freres(x)./coef(1),'k') 
      hold on 
      yaverage=yaverage./(coefaverage) 
      yaverage=yaverage./coef(1) 
      plot(x,yaverage,'bo') 
      hold on 
 
